Processing 00000000.tx.1: CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease Kaisu Luiro, Outi Kopra, Maarit Lehtovirta1 and Anu Jalanko+ National Public Health Institute, Department of Molecular Medicine, Biomedicum Helsinki, PO Box 104, Haartmaninkatu 8, FIN-00251 Helsinki, Finland and 1Department of Neurology, Kuopio University Hospital, 70211 Kuopio, Finland Received May 30, 2001; 

Phrase: "CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "targeted to neuronal synapses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0039062:Synapses [Body Space or Junction]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1521840:Targeted [Functional Concept]
   737 E C0598501:Synapsis [Cell Function]
   737 E C1633000:Synapsis [Plant]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "but"

Phrase: "excluded from synaptic vesicles"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0039065:Synaptic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
   737 E C1622418:vesicle [Cell Component]

Phrase: ":"

Phrase: "new clues to Batten disease Kaisu Luiro,"

Phrase: "Outi Kopra,"

Phrase: "Maarit Lehtovirta1"

Phrase: "and"

Phrase: "Anu Jalanko+ National Public Health Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C0027468:national health institute [Health Care Related Organization]
   799   C0021622:institute [Organization]
   799   C1272753:Institute [Idea or Concept]

Phrase: "Department of Molecular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Biomedicum Helsinki,"

Phrase: "PO Box 104,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179400:Box [Manufactured Object]
   827   C0442027:PO [Spatial Concept]
   827   C1533124:Box [Medical Device]

Phrase: "Haartmaninkatu 8,"

Phrase: "FIN-00251 Helsinki,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: "and"

Phrase: "1Department of Neurology,"

Phrase: "Kuopio University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "70211 Kuopio,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "May 30,"

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted July 16, 2001.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted July 16,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Batten disease (juvenile neuronal ceroid lipofuscinosis, JNCL), the most common neurodegenerative disease of childhood, is caused by mutations in the CLN3 gene encoding a putative transmembrane protein. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Batten disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0751383:Batten Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(juvenile neuronal ceroid lipofuscinosis,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0751383:Juvenile Neuronal Ceroid Lipofuscinosis [Disease or Syndrome]
           Neuronal lipofuscinosis, juvenile
  1000   C1413495:juvenile neuronal ceroid lipofuscinosis [Gene or Genome]
   923   C0027877:Ceroid-Lipofuscinosis, Neuronal [Disease or Syndrome]
           ceroid lipofuscinosis
   812   C0007831:Ceroid [Biologically Active Substance,Lipid]
   812   C0268279:Lipofuscinosis [Disease or Syndrome]
   812   C0521390:Neuronal [Immunologic Factor]
   741 E C0027882:Neuron [Cell]

Phrase: "JNCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:JNCL [Disease or Syndrome]
  1000   C1413495:JNCL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the most common neurodegenerative disease of childhood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]

Phrase: "is"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the CLN3 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413495:CLN3 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a putative transmembrane protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
Processing 00000000.tx.4: The function of CLN3 is currently unknown but it has been shown to localize in the endosomal/lysosomal compartments of non-neuronal cells. 

Phrase: "The function of CLN3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "currently unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "localize in the endosomal/lysosomal compartments of non-neuronal cells."
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   771   C0027836:Non-neuronal cell [Cell]
   755   C2349967:Compartment of cell [Anatomical Structure]
           Cell compartment
   742   C2330755:Compartment of lysosome [Body Space or Junction]
   742   C2336292:Compartment of endosome [Body Space or Junction]
   739   C0007634:Cells [Cell]
   739   C0392752:localize [Spatial Concept]
   739   C0521390:Neuronal [Immunologic Factor]
   739   C0521450:Lysosomal [Body Location or Region]
   739   C1185625:Compartments [Body Space or Junction]
   739   C1382196:Compartments [Natural Phenomenon or Process]
   739   C1518422:Non [Functional Concept]
   739   C3282337:Cells [Cell]
   724   C1948049:Cell (compartment) [Spatial Concept]
       E   Cell
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.5: In addition, several other intracellular localizations have been proposed and the controversy of the reports suggests that CLN3 may have different intracellular localization in different cell types. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other intracellular localizations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1660749:intracellular localization [Cell Function]
   861   C0475264:localizations [Functional Concept]
   827 E C1744691:localization [Biologic Function]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "and"

Phrase: "the controversy of the reports"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680243:controversy [Social Behavior]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "may"

Phrase: "have"

Phrase: "different intracellular localization in different cell types."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1660749:intracellular localization [Cell Function]
   774   C1660153:cell localization [Biologic Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.6: Batten disease severely affects neuronal cells but leaves other organs clinically unaffected, and thus it is ofutmost importance to approach the disease mechanism by studying the expression and localization of CLN3 in the brain and neuronal cells. 

Phrase: "Batten disease severely"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0751383:Batten Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "leaves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242724:Leaves [Plant]

Phrase: "other organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "clinically unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986417:Unaffected [Conceptual Entity]

Phrase: ","

Phrase: "and"

Phrase: "thus"

Phrase: "it"

Phrase: "is"

Phrase: "ofutmost importance to"

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "the disease mechanism by studying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "localization of CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: We have analysed here CLN3 in the mouse brain using in situ hybridization, immunohistochemical staining and western blot analysis of subcellular fractions. 

Phrase: "We"

Phrase: "have"

Phrase: "analysed"

Phrase: "here CLN3 in the mouse brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0751383:CLN3 [Disease or Syndrome]
   753   C1413495:CLN3 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in situ hybridization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "immunohistochemical staining"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "western blot analysis of subcellular fractions."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]
Processing 00000000.tx.8: As visual deterioration is the hallmark of Batten disease we have set up primary retinal cultures from the mouse and analysed both endogenous mouse CLN3 and Semliki Forest virus-mediated human CLN3 localization using immunofluorescence staining and confocal microscopy. 

Phrase: "As visual deterioration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0868945:Deterioration [Phenomenon or Process]

Phrase: "is"

Phrase: "the hallmark of Batten disease"

Phrase: "we"

Phrase: "have"

Phrase: "set up primary retinal cultures from the mouse"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0010453:Cultures [Idea or Concept]
   711 E C0220814:culture [Functional Concept]
   711 E C0430400:Culture [Laboratory Procedure]
   711 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "analysed"

Phrase: "both endogenous mouse CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0751383:CLN3 [Disease or Syndrome]
   827   C1413495:CLN3 [Gene or Genome]

Phrase: "and"

Phrase: "Semliki Forest virus-mediated human CLN3 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0475264:Localisation [Functional Concept]
   795   C1744691:localisation [Biologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunofluorescence staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "confocal microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.9: We demonstrate that CLN3 is abundantly expressed in neuronal cells, especially in the cortex, hippocampus and cerebellum of the adult mouse brain. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "abundantly"

Phrase: "expressed in neuronal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "especially in the cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C2700441:Cortex [Plant]

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum of the adult mouse brain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1522278:Mouse Cerebellum [Tissue]
   783   C1707522:BRAIN, CEREBELLUM [Tissue]
           Cerebellum
   753   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   753   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.10: Furthermore, our results indicate that in neurons CLN3 is not solely a lysosomal protein. 

Phrase: "Furthermore,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that in neurons CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C0751383:CLN3 [Disease or Syndrome]
   770   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "not solely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "a lysosomal protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.11: It is localized in the synaptosomes but, interestingly, is not targeted to the synaptic vesicles. 

Phrase: "It"

Phrase: "is"

Phrase: "localized in the synaptosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039067:Synaptosomes [Cell Component]
   770   C0392752:Localized [Spatial Concept]

Phrase: "but"

Phrase: ","

Phrase: "interestingly,"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "targeted to the synaptic vesicles."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0039065:Synaptic Vesicles [Cell Component]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1521840:Targeted [Functional Concept]
   726 E C1622418:vesicle [Cell Component]
   726 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.12: The novel localization of CLN3 directs attention towards molecular alterations at the synapses. 

Phrase: "The novel localization of CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "attention towards molecular alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004268:Attention [Mental Process]

Phrase: "at the synapses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0039062:Synapses [Body Space or Junction]
   966 E C0598501:Synapsis [Cell Function]
   966 E C1633000:Synapsis [Plant]
Processing 00000000.tx.13: This should yield important clues about the mechanisms of neurodegeneration in Batten disease.  

Phrase: "This"

Phrase: "should"

Phrase: "yield"

Phrase: "important clues about the mechanisms of neurodegeneration"

Phrase: "in Batten disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0751383:Batten Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Batten disease (juvenile-onset neuronal ceroid lipofuscinosis or SpielmeyerVogtSjgren disease) is the most common neurodegenerative disease of childhood with an incidence of 1in 21 000 (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Batten disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0751383:Batten Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(juvenile-onset neuronal ceroid lipofuscinosis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   933   C0751383:Juvenile Neuronal Ceroid Lipofuscinosis [Disease or Syndrome]
           Neuronal lipofuscinosis, juvenile
   933   C1413495:juvenile neuronal ceroid lipofuscinosis [Gene or Genome]
   884   C0027877:Ceroid-Lipofuscinosis, Neuronal [Disease or Syndrome]
           ceroid lipofuscinosis
   804   C0007831:Ceroid [Biologically Active Substance,Lipid]
   804   C0268279:Lipofuscinosis [Disease or Syndrome]
   804   C0521390:Neuronal [Immunologic Factor]
   733 E C0027882:Neuron [Cell]

Phrase: "or"

Phrase: "SpielmeyerVogtSjgren disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "the most common neurodegenerative disease of childhood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]

Phrase: "with an incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "of 1in 21 000"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: This autosomal recessively inherited disease is caused by mutations in the CLN3 gene, identified in 1995 (2). 

Phrase: "This autosomal recessively inherited disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0019247:Inherited disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0439660:Inherited [Functional Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the CLN3 gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413495:CLN3 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "identified in 1995"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: It belongs to a group of at least eight inherited progressive neurodegenerative diseases called neuronal ceroid lipofuscinoses (NCLs) (for a review see see refs 1 and 3). 

Phrase: "It"

Phrase: "belongs to a group of"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0441835:Group A [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "at least eight inherited progressive neurodegenerative diseases"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   841   C0019247:Inherited disease [Disease or Syndrome]
   827   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   822   C0677932:progressive disease [Neoplastic Process]
   822   C1335499:Progressive Disease [Finding]
   822   C3539781:Progressive Disease [Disease or Syndrome]
   799   C0012634:Diseases [Disease or Syndrome]
   727 E C1836721:MALS [Finding]
   727 E C3538764:MALS [Gene or Genome]
   727 E C3540595:MAL [Gene or Genome]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "neuronal ceroid lipofuscinoses (NCLs)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0027877:Neuronal Ceroid-Lipofuscinoses [Disease or Syndrome]
           ceroid lipofuscinosis
   827   C0007831:Ceroid [Biologically Active Substance,Lipid]
   827   C0521390:Neuronal [Immunologic Factor]
   793   C0268279:Lipofuscinosis [Disease or Syndrome]
   755 E C0027882:Neuron [Cell]

Phrase: "("

Phrase: "for a review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "refs 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332102:REF-1 [Gene or Genome]
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: NCL diseases are marked by two histopathological findings: degeneration of nerve cells, foremost in the cerebral cortex, and accumulation of autofluorescent ceroid-lipopigment in both neural and peripheral tissues (4). 

Phrase: "NCL diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "marked by two histopathological findings"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0205448:Two [Quantitative Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   754   C0428093:Histopathology finding [Laboratory or Test Result]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: ":"

Phrase: "degeneration of nerve cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0027746:Nerve Degeneration [Cell or Molecular Dysfunction]
   819   C0333467:cells degeneration [Pathologic Function]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "foremost in the cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "accumulation of autofluorescent ceroid-lipopigment"

Phrase: "in both neural"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0599851:Neural [Functional Concept]
   944 E C0027740:Nerve [Tissue]
   944 E C0027757:NERVE [Tissue]
   944 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   907 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "peripheral tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.18: In Batten disease, the autofluorescent material has been identified as mitochondrial ATP synthase subunit c (5). 

Phrase: "In Batten disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0751383:Batten Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the autofluorescent material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "has"

Phrase: "been"

Phrase: "identified as mitochondrial ATP synthase subunit c (5"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0949692:Mitochondrial ATP Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205396:Identified [Qualitative Concept]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C1550043:Identified [Finding]
   744   C1551388:Identified [Functional Concept]
   744   C1711351:Subunit [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: The clinical features of Batten disease include visual failure, epileptic seizures and progressive dementia, which lead to premature death at the age of 1830 years (6). 

Phrase: "The clinical features of Batten disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "visual failure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "epileptic seizures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0014544:Epileptic Seizures [Disease or Syndrome]
           Epileptic
   861   C0036572:Seizures [Sign or Symptom]
   827 E C1959629:Seizure [Finding]

Phrase: "and"

Phrase: "progressive dementia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0743039:Dementia, progressive [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "which"

Phrase: "lead to premature death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1855073:Premature Death [Finding]
   770   C0011065:Death [Organism Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0205252:Premature [Temporal Concept]
   770   C1306577:Death, NOS [Finding]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "at the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 1830 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.20: Most patients carry a 1.02 kb deletion removing nucleotides 461677 from the CLN3 coding region; 

Phrase: "Most patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "a 1.02 kb deletion removing nucleotides 461677 from the CLN3 coding region"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   750   C0079941:Coding Region [Gene or Genome]
   735   C0009219:Coding [Occupational Activity]
   735   C0017446:Region [Geographic Area]
   735   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   735   C0205147:Region [Spatial Concept]
   735   C0751383:CLN3 [Disease or Syndrome]
   735   C1413495:CLN3 [Gene or Genome]
   735   C1442161:Deletion [Cell or Molecular Dysfunction]
   735   C1511760:Deletion [Genetic Function]
   735   C1880274:Deletion [Activity]
   702 E C0805701:Code [Intellectual Product]
   702   C0849355:remove [Qualitative Concept]
   702   C1883720:Remove [Activity]
   702   C3244314:remove [Functional Concept]

Phrase: ";"
Processing 00000000.tx.21: in addition, 24 mutations and two polymorphisms have been characterized (3). 

Phrase: "in addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "24 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "two polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: The CLN3 protein is an integral transmembrane protein with several very hydrophobic domains (7). 

Phrase: "The CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "an integral transmembrane protein with several very hydrophobic domains"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   762   C0162808:Protein Domains [Spatial Concept]
   745 E C1514562:Protein Domain [Amino Acid Sequence]
   745   C1519623:Transmembrane Domain [Amino Acid Sequence]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1167322:transmembrane [Cell Component]
   742   C2752508:transmembrane [Cell Component]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.23: It is conserved among different species indicating a fundamental role in cell metabolism. 

Phrase: "It"

Phrase: "is"

Phrase: "conserved among different species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0178849:species difference [Biologic Function]
   770   C1705242:Different [Qualitative Concept]
   770   C1705920:Species [Conceptual Entity]

Phrase: "indicating"

Phrase: "a fundamental role in cell metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0025519:Metabolism [Organism Function]
   804   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.24: Studies using the yeast cln3 homologue BTN1p knockout strain have indicated that the CLN3 protein may have a role in the regulation of the vacuolar pH (8). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast cln3 homologue BTN1p knockout strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0080194:Strain [Injury or Poisoning]
   799   C0456178:strain [Intellectual Product]
   799   C1518614:Strain [Organism]
   799   C2987481:Strain [Mental Process]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "have"

Phrase: "a role in the regulation of the vacuolar pH (8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.25: How this putative finding relates to the pathology of Batten disease still remains elusive. 

Phrase: "How"

Phrase: "this putative finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "relates to the pathology of Batten disease still"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0087031:disease still [Disease or Syndrome]
   770   C0751383:Batten Disease [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030664:Pathology [Biomedical Occupation or Discipline]
   744   C0163712:Relate [Organic Chemical]
   744   C0205469:pathology [Functional Concept]
   744   C0677042:pathology [Pathologic Function]

Phrase: "remains"

Phrase: "elusive."
Processing 00000000.tx.26: We have previously demonstrated the endosomal/lysosomal localization of CLN3 protein in non-neuronal cells (9). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "demonstrated"

Phrase: "the endosomal/lysosomal localization of CLN3 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0597704:protein localisation [Cell Function]
   774   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
   743   C1819332:lysosome localisation [Biologic Function]
   738   C1819354:endosome localisation [Biologic Function]

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.27: In addition, several other intracellular localizations have been proposed for CLN3; 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other intracellular localizations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1660749:intracellular localization [Cell Function]
   861   C0475264:localizations [Functional Concept]
   827 E C1744691:localization [Biologic Function]

Phrase: "have"

Phrase: "been"

Phrase: "proposed for CLN3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0751383:CLN3 [Disease or Syndrome]
   790   C1413495:CLN3 [Gene or Genome]
   790   C1441414:PROPOSED [Idea or Concept]
   790   C1553874:Proposed [Qualitative Concept]
   790   C1578820:Proposed [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.28: endoplasmic reticulum (10), Golgi (11) and cell membranes and nucleus (12) in non-neuronal cells. 

Phrase: "endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "cell membranes"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0007603:Cell membranes [Cell Component]
   966 E C3161472:Cell Membrane [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0025255:Membranes [Tissue]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(12"

Phrase: ")"

Phrase: "in non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.29: In neurons CLN3 localization has been just tentatively examined and it seems that the protein is trafficked along the neural extensions (13) and one report indicates mitochondrial localization in retinal cells as detected by immunochemical analyses (14). 

Phrase: "In neurons CLN3 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "just tentatively"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "it"

Phrase: "seems"

Phrase: "that"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "trafficked along the neural extensions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0231448:extensions [Functional Concept]
   760   C0599851:Neural [Functional Concept]
   760   C0599896:trafficked [Cell Function]
   726 E C1880641:Extension [Conceptual Entity]
   704 E C0027740:Nerve [Tissue]
   704 E C0027757:NERVE [Tissue]
   704 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "one report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "indicates"

Phrase: "mitochondrial localization in retinal cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1657244:mitochondrial localization [Biologic Function]
   781   C1660153:cell localization [Biologic Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "as"

Phrase: "detected by immunochemical analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.30: The fact that the reports on the intracellular localization of CLN3 protein have been quite controversial suggest that CLN3 may have different intracellular localization in different cells. 

Phrase: "The fact"

Phrase: "that"

Phrase: "the reports on the intracellular localization of CLN3 protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0684224:Reports [Intellectual Product]
   742   C0700287:reports [Health Care Activity]
   708 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "quite controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0680243:controversies [Social Behavior]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "may"

Phrase: "have"

Phrase: "different intracellular localization in different cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1660749:intracellular localization [Cell Function]
   767   C1660153:cell localization [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.31: Due to the fact that Batten disease severely affects neuronal cells and leaves other organs clinically unaffected, it is of utmost importance to approach the disease mechanism by studying the expression and localization of CLN3 in the brain and neuronal cells. 

Phrase: "Due to the fact"

Phrase: "that Batten disease severely"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0751383:Batten Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "leaves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242724:Leaves [Plant]

Phrase: "other organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "clinically unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986417:Unaffected [Conceptual Entity]

Phrase: ","

Phrase: "it"

Phrase: "is of utmost importance to"

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "the disease mechanism by studying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "localization of CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0475264:Localisation [Functional Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.32: We have analysed here, CLN3 in mouse brain using in situ hybridization, immunohistochemical staining and western blot analysis of subcellular fractions. 

Phrase: "We"

Phrase: "have"

Phrase: "analysed"

Phrase: "here,"

Phrase: "CLN3 in mouse brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0751383:CLN3 [Disease or Syndrome]
   770   C1413495:CLN3 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in situ hybridization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "immunohistochemical staining"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "western blot analysis of subcellular fractions."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]
Processing 00000000.tx.33: Furthermore, as visual deterioration is the hallmark of Batten disease as well as all NCL disorders, we have set up primary retinal cultures from the mouse and analysed both endogenous mouse CLN3 and Semliki Forest virus (SFV)-mediated human CLN3 localization using immunofluorescence staining and confocal microscopy. 

Phrase: "Furthermore,"

Phrase: "as"

Phrase: "visual deterioration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0868945:Deterioration [Phenomenon or Process]

Phrase: "is"

Phrase: "the hallmark of Batten disease"

Phrase: "as well as"

Phrase: "all NCL disorders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "we"

Phrase: "have"

Phrase: "set up primary retinal cultures from the mouse"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0010453:Cultures [Idea or Concept]
   711 E C0220814:culture [Functional Concept]
   711 E C0430400:Culture [Laboratory Procedure]
   711 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "analysed"

Phrase: "both endogenous mouse CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0751383:CLN3 [Disease or Syndrome]
   827   C1413495:CLN3 [Gene or Genome]

Phrase: "and"

Phrase: "Semliki Forest virus (SFV)-mediated human CLN3 localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0475264:Localisation [Functional Concept]
   795   C1744691:localisation [Biologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunofluorescence staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "confocal microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.34: Our results indicate that CLN3 has alternative trafficking routes depending on the cell type. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "has"

Phrase: "alternative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1523987:Alternative [Conceptual Entity]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "routes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0449444:routes [Spatial Concept]
   966 E C0013153:ROUTE [Functional Concept]
   966 E C1879941:ROUTE [Intellectual Product]

Phrase: "depending on the cell type."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007634:Cell Type [Cell]
           Cell
   806   C0449475:cell type [Intellectual Product]
   760   C0332307:Type [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1547052:*Type [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0725813:depend [Medical Device]
Processing 00000000.tx.35: In neuronal cells CLN3 is not specifically targeted to lysosomes, but the bulk of the protein is found in the synaptosomal fraction. 

Phrase: "In neuronal cells CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0751383:CLN3 [Disease or Syndrome]
   827   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "not specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "targeted to lysosomes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0024369:Lysosomes [Cell Component]
   790   C1521840:Targeted [Functional Concept]
   756 E C2984253:Lysosome [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "but"

Phrase: "the bulk of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012173:Bulk [Food]
   760   C1337615:Bulk [Biomedical or Dental Material]

Phrase: "is"

Phrase: "found in the synaptosomal fraction."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.36: CLN3 protein is not, however, targeted to synaptic vesicles (SVs) such as the other NCL protein palmitoyl protein thioesterase (PPT1) (15), indicating a yet unknown membrane compartment for CLN3 in neurons.  

Phrase: "CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "however,"

Phrase: "targeted to synaptic vesicles (SVs)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0039065:Synaptic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C1521840:Targeted [Functional Concept]
   737 E C1622418:vesicle [Cell Component]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "such as the"

Phrase: "other NCL protein palmitoyl protein thioesterase (PPT1)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   888   C0380804:protein palmitoyl thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
           palmitoyl-protein thioesterase
   884   C1418854:PALMITOYL-PROTEIN THIOESTERASE [Gene or Genome]
   853   C0030238:Palmitoyl Thioesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "a yet unknown membrane compartment for CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1185625:Compartment [Body Space or Junction]
   748   C2986730:Compartment [Spatial Concept]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.37: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  CLN3 is expressed in neural cells of mouse brain We first studied the expression and localization of the CLN3 gene and CLN3 protein in adult mouse brain (2.5- and 6-month-old animals) using in situ hybridization and immunohistochemistry. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "expressed in neural cells of mouse brain"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   778   C1521713:Mouse Brain [Tissue]
   774   C0596208:brain cells [Cell]
   762   C0027882:Neural cell [Cell]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0599851:Neural [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   746   C1514123:Mouse Nerve [Tissue]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   713 E C0027762:Nervous Mouse [Mammal]

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "localization of the CLN3 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0008630:Gene Localization [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "CLN3 protein in adult mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0531443:CLN3 protein, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2.5-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "6-month-old animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "and"

Phrase: "immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.38: Both methods resulted in a very similar distribution pattern showing that most expression was concentrated on the neuronal cells. 

Phrase: "Both methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "resulted in a very similar distribution pattern"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0449775:Distribution pattern [Spatial Concept]
   748   C0442824:Very [Qualitative Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]
   748   C2348205:Similar [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "most expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "concentrated on the neuronal cells."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2003864:Concentrate [Substance]
Processing 00000000.tx.39: No difference between the 2.5- and 6-month-old mice was detected in terms of the intensities or distribution of CLN3 expression (results only for the 2.5-month-old mice shown). 

Phrase: "No difference between the 2.5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "6-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "detected in terms of the intensities"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0442726:Detected [Finding]
   753   C0522510:intensities [Qualitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719   C1515273:Term [Temporal Concept]
   719   C1705313:Term [Idea or Concept]
   719   C2826302:TERM [Intellectual Product]

Phrase: "or"

Phrase: "distribution of CLN3 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "(results only for the 2.5-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.40: CLN3 mRNA and protein were detected throughout the brain, for example, in the cerebral cortex, hippocampus, cerebellum and several different cerebral nuclei (Figs 1 and 2). 

Phrase: "CLN3 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected throughout the brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in the cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "several different cerebral nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0458265:Cerebral nucleus [Body Part, Organ, or Organ Component]
   779   C0007610:Nucleus [Cell Component]

Phrase: "(Figs 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.41: In the cerebral cortex, CLN3-positive cells were found in all cortical layers, although not all neurons were labelled (Figs 1A and 2A). 

Phrase: "In the cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "CLN3-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "found in all cortical layers,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0150312:Found [Quantitative Concept]
   760   C0934502:layers [Body Part, Organ, or Organ Component]
   726 E C0243095:Find [Finding]
   726 E C1522408:Layer [Qualitative Concept]
   726 E C1561599:Layer [Intellectual Product]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "labelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181496:Label [Manufactured Object]
   966   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Figs 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "2A"

Phrase: ")."
Processing 00000000.tx.42: In the hippocampus, the most prominent CLN3 expression was detected in the granule cells in the dentate gyrus and the pyramidal cells of the hippocampus proper (Figs 1B and 2A and B). 

Phrase: "In the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "the most prominent CLN3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected in the granule cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   781   C0010837:Cell granule [Cell Component]
           Granule
   773 E C0596630:granule cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0442726:Detected [Finding]
   760   C0993609:Granule [Biomedical or Dental Material]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in the dentate gyrus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
  1000   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the pyramidal cells of the hippocampus"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0206441:Pyramidal Cells [Cell]
   767   C0007634:THE CELL [Cell]
           Cells
   756 E C2334588:Pyramidal cell [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "proper"

Phrase: "(Figs 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "2A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.43: In the cerebellum intense mRNA signal as well as protein immunolabelling was detected in the granular and molecular layers, and in the Purkinje cell layer (Figs 1C and 2C). 

Phrase: "In the cerebellum intense mRNA signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "as well as"

Phrase: "protein immunolabelling"

Phrase: "was"

Phrase: "detected in the granular"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0010837:Granular [Cell Component]
   770   C0205248:Granular [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "molecular layers,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   861   C1521991:Molecular [Qualitative Concept]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]
   789 E C0567416:Molecule [Substance]

Phrase: "and in the Purkinje cell layer"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0228470:Purkinje cell layer [Tissue]
   790   C0034143:Purkinje cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(Figs 1C"

Phrase: "and"

Phrase: "2C"

Phrase: ")."
Processing 00000000.tx.44: In terms of intracellular localization, neurons were immunopositive near the plasma membrane, and especially in some granularly stained large neurons the immunostaining was also seen in the neurites (Fig.2D). 

Phrase: "In terms of intracellular localization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1660749:intracellular localization [Cell Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "immunopositive near the plasma membrane,"

Phrase: "and"

Phrase: "especially in some granularly stained large neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   762   C0228072:Large neuron [Cell]
   748   C0027882:Neurons [Cell]
   748   C0549177:Large [Quantitative Concept]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "the immunostaining"

Phrase: "was"

Phrase: "also"

Phrase: "seen in the neurites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0085103:Neurites [Cell Component]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.45: View larger version (99K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(99K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.46: In situ hybridization analysis of CLN3 mRNA in brain sections of 2.5-month-old mouse. 

Phrase: "In situ hybridization analysis of CLN3 mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "of 2.5-month-old mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]
Processing 00000000.tx.47: (A) High expression of CLN3 is seen in the cerebral cortex (CTX). 

Phrase: "(A) High expression of CLN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "seen in the cerebral cortex (CTX)."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C0205397:Seen [Qualitative Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.48: (B) In the hippocampus, CLN3 is expressed in the principal cells, pyramidal cells (PC) and granular cells (GC). 

Phrase: "(B) In the hippocampus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347469:/B [Quantitative Concept]

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "expressed in the principal cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205225:Principal [Qualitative Concept]
   760   C0401925:Principal [Professional or Occupational Group]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "pyramidal cells (PC)"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0206441:Pyramidal Cells [Cell]
   966 E C2334588:Pyramidal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "granular cells (GC)."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0007634:Cells [Cell]
   861   C0010837:Granular [Cell Component]
   861   C0205248:Granular [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.49: (C) In the cerebellum, CLN3 is highly expressed in the Purkinje cell layer (PCL) and in the granular layer (GL). 

Phrase: "(C) In"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "the cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in the Purkinje cell layer (PCL)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0228470:Purkinje cell layer [Tissue]
   790   C0034143:Purkinje cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1269647:Cell [Cell]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and in the granular layer (GL)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0221923:Granular Layer [Tissue]
   760   C0010837:Granular [Cell Component]
   760   C0205248:Granular [Qualitative Concept]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]
Processing 00000000.tx.50: Expression is also evident in the molecular layer (ML). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also evident in the molecular layer (ML)."
Processing 00000000.tx.51: Positive signal is shown as purple-black. 

Phrase: "Positive signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "shown as purple-black."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0439541:Black [Qualitative Concept]
   770   C0439542:Purple [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.52: Scale bar, 250 m.  

Phrase: "Scale bar,"

Phrase: "250 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.53: View larger version (153K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(153K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.54: Distribution of CLN3 immunopositivity in brain sections of 2.5-month-old mouse. 

Phrase: "Distribution of CLN3 immunopositivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "of 2.5-month-old mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]
Processing 00000000.tx.55: (A) CLN3 immunostaining with the mouse CLN3 antibody (m385/CLN3) in the hippocampus (HC) is especially evident in the pyramidal cells (PC). 

Phrase: "(A) CLN3 immunostaining with the mouse CLN3 antibody"

Phrase: "(m385/CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751383:CLN3 [Disease or Syndrome]
   861   C1413495:CLN3 [Gene or Genome]

Phrase: ")"

Phrase: "in the hippocampus (HC)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "especially evident in the pyramidal cells"

Phrase: "(PC"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0206441:Pyramidal Cells [Cell]
   966 E C2334588:Pyramidal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.56: The cortical areas (CTX) above the HC show numerous neurons strongly immunopositive for CLN3, although negative cells are also intermingled with them. 

Phrase: "The cortical areas"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   861   C0001613:Cortical [Body Part, Organ, or Organ Component]
   861   C0007776:Cortical [Body Part, Organ, or Organ Component]
   861   C0022655:Cortical [Body Part, Organ, or Organ Component]
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]
   805 E C0234875:bark [Organism Attribute]
   805 E C2700441:Bark [Plant]
   777 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   777 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "(CTX"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: ")"

Phrase: "above the HC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "numerous neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "strongly immunopositive for CLN3,"

Phrase: "although"

Phrase: "negative cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "also"

Phrase: "intermingled with them."
Processing 00000000.tx.57: (B) A higher magnification of the hippocampal pyramidal cells at the CA1 region. 

Phrase: "(B) A higher magnification of the hippocampal pyramidal cells"

Phrase: "at the CA1 region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.58: (C) CLN3 immunopositivity in the cerebellum is strong in the Purkinje cell layer (PCL) and granular layer (GL), and also observable in the molecular layer (ML). 

Phrase: "(C) CLN3 immunopositivity in the cerebellum"

Phrase: "is"

Phrase: "strong in the Purkinje cell layer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442821:Strong [Qualitative Concept]

Phrase: "(PCL"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0228470:Purkinje cell layer [Tissue]
   901   C0034143:Purkinje cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "granular layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0221923:Granular Layer [Tissue]
   861   C0010837:Granular [Cell Component]
   861   C0205248:Granular [Qualitative Concept]
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "(GL"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0221923:Granular Layer [Tissue]
   861   C0010837:Granular [Cell Component]
   861   C0205248:Granular [Qualitative Concept]
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "also observable in the molecular layer"

Phrase: "(ML"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1521991:Molecular [Qualitative Concept]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]
   789 E C0567416:Molecule [Substance]

Phrase: ")."
Processing 00000000.tx.59: (D) A higher magnification of neuronal cells in the hypothalamus showing granular CLN3 immunostaining throughout the cell soma as well as in the neurites (arrowheads). 

Phrase: "(D) A higher magnification of neuronal cells"

Phrase: "in the hypothalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "granular CLN3 immunostaining throughout the cell soma"

Phrase: "as well as in the neurites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0085103:Neurites [Cell Component]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.60: Positivity is most prominent near the plasma membrane of the cell. 

Phrase: "Positivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   928   C0439178:% Positive [Quantitative Concept]
   928   C1446409:Positive [Qualitative Concept]
   928   C1514241:Positive [Finding]
   928   C2825490:Positive [Qualitative Concept]

Phrase: "is"

Phrase: "most prominent near the plasma membrane of the cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205402:Prominent [Qualitative Concept]
Processing 00000000.tx.61: Immunoreactivity is seen in brown and counterstaining in blue. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "is"

Phrase: "seen in brown"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C0678579:Brown [Natural Phenomenon or Process]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "counterstaining in blue."
Processing 00000000.tx.62: Scale bar: (A and C) 160 m; 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "(A"

Phrase: "and"

Phrase: "C) 160 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.63: (B and D) 40 m.  

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)"

Phrase: "40 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.64: CLN3 co-localizes with presynaptic proteins in retinal cells In order to elucidate the localization of endogenous CLN3, double immunostaining with mouse CLN3-specific peptide antibody and several antibodies against specific cellular compartments in mouse primary retinal cultures was performed. 

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "co-localizes with presynaptic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0392752:localize [Spatial Concept]

Phrase: "in retinal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2338017:Retinal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the localization of endogenous CLN3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "double immunostaining with mouse CLN3-specific peptide antibody"

Phrase: "and"

Phrase: "several antibodies against specific cellular compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in mouse primary retinal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.65: Endogenous CLN3 is clearly visible in retinal cultures prepared from embryonic day (E)14.516.5 mice. 

Phrase: "Endogenous CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751383:CLN3 [Disease or Syndrome]
   861   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "clearly visible in retinal cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "prepared from embryonic day (E)14.516.5 mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0013935:Embryonic [Embryonic Structure]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0332173:/day [Temporal Concept]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]
   711   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.66: Firstly, CLN3 protein was seen to co-localize clearly with a specific neuronal marker, mouse anti-tubulin  III isoform (Fig. 3A). 

Phrase: "Firstly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279901:Firstly [Qualitative Concept]

Phrase: "CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "seen to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0205397:Seen [Qualitative Concept]
   799 E C0042789:see [Organism Function]
   799 E C1947903:See [Activity]

Phrase: "co-localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:localize [Spatial Concept]

Phrase: "clearly with a specific neuronal marker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005516:Marker [Clinical Attribute]
   753   C0205369:Specific [Qualitative Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1552740:specific [Intellectual Product]

Phrase: "mouse anti-tubulin  III isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.67: More specifically, CLN3 protein is seen in the neural extensions and synaptic terminals. 

Phrase: "More specifically,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "seen in the neural extensions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   760   C0205397:Seen [Qualitative Concept]
   760   C0231448:extensions [Functional Concept]
   760   C0599851:Neural [Functional Concept]
   726 E C0042789:see [Organism Function]
   726 E C1880641:Extension [Conceptual Entity]
   726 E C1947903:See [Activity]
   704 E C0027740:Nerve [Tissue]
   704 E C0027757:NERVE [Tissue]
   704 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "synaptic terminals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Synaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.68: This is supported by a significant degree of co-localization with pre-synaptic markers SV2 (Fig. 3B) and SYP (similar to SV2 staining, data not shown). 

Phrase: "This"

Phrase: "is"

Phrase: "supported by a significant degree of co-localization"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   744   C0237881:significant [Quantitative Concept]
   744   C0441889:Degree [Qualitative Concept]
   744   C0449286:Degree [Quantitative Concept]
   744   C0475264:Localisation [Functional Concept]
   744   C0542560:Degree [Intellectual Product]
   744   C0750502:Significant [Idea or Concept]
   744   C1521721:Supported [Conceptual Entity]
   744   C1546944:Significant [Qualitative Concept]
   744   C1561545:degree [Quantitative Concept]
   744   C1744691:localisation [Biologic Function]
   744   C2348088:Degree [Quantitative Concept]
   711 E C0183683:Support [Medical Device]

Phrase: "with pre-synaptic markers SV2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1427005:SV2 [Gene or Genome]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "SYP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420554:SYP [Gene or Genome]

Phrase: "(similar to SV2 staining,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.69: In the axonal parts of the neurons, CLN3 protein can be seen to co-localize partially with the growth-associated protein, GAP-43 (Fig. 3DF). 

Phrase: "In the axonal parts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   947   C1178981:axon part [Cell Component]
   861   C0449719:parts [Spatial Concept]
   861   C1709471:PARTS [Quantitative Concept]

Phrase: "of the neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "seen to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0205397:Seen [Qualitative Concept]
   799 E C0042789:see [Organism Function]
   799 E C1947903:See [Activity]

Phrase: "co-localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:localize [Spatial Concept]

Phrase: "partially with the growth-associated protein,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   783   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0018270:'growth' NOS [Organism Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "GAP-43"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Fig. 3DF"

Phrase: ")."
Processing 00000000.tx.70: GAP-43 is a major protein of neuronal growth cones and certain presynaptic terminals, and a candidate for involvement in both axon growth and synaptic plasticity. 

Phrase: "GAP-43"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "a major protein of neuronal growth cones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "certain presynaptic terminals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206181:Presynaptic Terminals [Cell Component]
   793   C0205088:Terminal [Temporal Concept]
   793   C1705314:Terminal [Manufactured Object]
   793   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "a candidate for involvement"

Phrase: "in both axon growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749784:axon growth [Organ or Tissue Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "synaptic plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]
Processing 00000000.tx.71: The horizontal XZ-projection of the confocal image, however, indicates that CLN3 and GAP-43 are not localized in the same subcellular compartment (Fig. 3F, insert). 

Phrase: "The horizontal XZ-projection of the confocal image,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0442301:Horizontal projection [Spatial Concept]
   744   C0016538:Projection [Intellectual Product]
   744   C0033363:Projection [Mental Process]
   744   C0348018:Projection [Spatial Concept]

Phrase: "however,"

Phrase: "indicates"

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "and"

Phrase: "GAP-43"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "localized in the same subcellular compartment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0392752:Localized [Spatial Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1185625:Compartment [Body Space or Junction]
   753   C2986730:Compartment [Spatial Concept]

Phrase: "(Fig. 3F,"

Phrase: "insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441587:Insert [Health Care Activity]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: ")."
Processing 00000000.tx.72: On the other hand, there was no obvious co-localization of CLN3 with the lysosomal marker Lamp1 (Fig. 3C). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no obvious co-localization of CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "with the lysosomal marker Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1416788:LAMP1 [Gene or Genome]
   827   C3540818:LAMP-1 [Gene or Genome]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: Lamp1-positive vesicles are predominant in the soma whereas CLN3 is found in the neural extensions. 

Phrase: "Lamp1-positive vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "are"

Phrase: "predominant in the soma"

Phrase: "whereas"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "found in the neural extensions."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C0231448:extensions [Functional Concept]
   760   C0599851:Neural [Functional Concept]
   726 E C0243095:Find [Finding]
   726 E C1880641:Extension [Conceptual Entity]
   704 E C0027740:Nerve [Tissue]
   704 E C0027757:NERVE [Tissue]
   704 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.74: In the soma, CLN3 can be seen to localize near the plasma membrane. 

Phrase: "In the soma,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "localize near the plasma membrane."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0392752:localize [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.75: In embryonic cortical neurons endogenous CLN3 was not detectable (data not shown) further indicating that retinal cultures provide an optimal model for the analysis of CLN3 protein trafficking. 

Phrase: "In embryonic cortical neurons endogenous CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0751383:CLN3 [Disease or Syndrome]
   804   C1413495:CLN3 [Gene or Genome]

Phrase: "was"

Phrase: "not detectable"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "indicating"

Phrase: "that retinal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an optimal model for the analysis of CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "trafficking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]
Processing 00000000.tx.76: View larger version (23K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.77: Confocal immunofluorescence analysis of endogenous CLN3 and subcellular markers in mouse retinal cells. 

Phrase: "Confocal immunofluorescence analysis of endogenous CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "subcellular markers in mouse retinal cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.78: Neurons were double immunostained with polyclonal rabbit m385/CLN3 antibody (red) and monoclonal mouse antibodies for -tubulin, SV2, GAP-43 and rat anti-Lamp1 antibody (green). 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "immunostained with polyclonal rabbit m385/CLN3 antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   748   C0751383:CLN3 [Disease or Syndrome]
   748   C1413495:CLN3 [Gene or Genome]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "monoclonal mouse antibodies for -tubulin,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   824   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   797   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "SV2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427005:SV2 [Gene or Genome]

Phrase: "GAP-43"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "rat anti-Lamp1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.79: (A) CLN3 and the neuronal marker -tubulin show partial co-localization (yellow). 

Phrase: "(A) CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751383:CLN3 [Disease or Syndrome]
   861   C1413495:CLN3 [Gene or Genome]

Phrase: "and"

Phrase: "the neuronal marker -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2937342:tubulin [Cell Component]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "partial co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "(yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.80: (B) CLN3 also shows partial co-localization with the presynaptic marker SV2 (arrowhead). 

Phrase: "(B) CLN3 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0751383:CLN3 [Disease or Syndrome]
   827   C1413495:CLN3 [Gene or Genome]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "partial co-localization with the presynaptic marker SV2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")."
Processing 00000000.tx.81: (C) CLN3 and Lamp1 show no obvious co-localization as Lamp1 is retained in the cell soma but CLN3 is also seen along the neural extensions. 

Phrase: "(C) CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751383:CLN3 [Disease or Syndrome]
   861   C1413495:CLN3 [Gene or Genome]

Phrase: "and"

Phrase: "Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416788:LAMP1 [Gene or Genome]
  1000   C3540818:LAMP-1 [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no obvious co-localization as Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "retained in the cell soma"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0599444:Cell soma [Cell Component]
           soma
   806   C2752549:cell soma [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0333118:Retained [Functional Concept]
   760   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   751 E C1257909:Somatic cell [Cell]
   704 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "seen along the neural extensions."
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   760   C0205397:Seen [Qualitative Concept]
   760   C0231448:extensions [Functional Concept]
   760   C0599851:Neural [Functional Concept]
   726 E C0042789:see [Organism Function]
   726 E C1880641:Extension [Conceptual Entity]
   726 E C1947903:See [Activity]
   704 E C0027740:Nerve [Tissue]
   704 E C0027757:NERVE [Tissue]
   704 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.82: (D) CLN3 and GAP-43 immunostainings show partial co-localization in the same axon. 

Phrase: "("

Phrase: "D)"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "and"

Phrase: "GAP-43 immunostainings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "partial co-localization in the same axon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.83: Insert shows the XZ-projection of the axonal varicosity indicating that GAP-43 and CLN3 are not localized in the same subcellular compartment. 

Phrase: "Insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441587:Insert [Health Care Activity]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the XZ-projection of the axonal varicosity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0016538:Projection [Intellectual Product]
   748   C0033363:Projection [Mental Process]
   748   C0348018:Projection [Spatial Concept]

Phrase: "indicating"

Phrase: "that GAP-43"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "localized in the same subcellular compartment."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0392752:Localized [Spatial Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1185625:Compartment [Body Space or Junction]
   753   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.84: Scale bar: (A) 20 m; 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "(A) 20 m"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C2346751:A/m [Quantitative Concept]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.85: (BF) 10 m.  

Phrase: "(BF) 10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.86: We further assessed the localization of overexpressed human CLN3 in retinal cultures using SFV-CLN3-mediated expression. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the localization of overexpressed human CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in retinal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SFV-CLN3-mediated expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.87: The results of double immunostaining with the human CLN3-specific peptide antibody (9) and several specific organelle markers were similar to those seen in the endogenous mouse CLN3 staining. 

Phrase: "The results of double immunostaining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "with the human CLN3-specific peptide antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "several specific organelle markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen in the endogenous mouse CLN3 staining."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0205227:Endogenous [Functional Concept]
   748   C0205397:Seen [Qualitative Concept]
   748   C0487602:Staining [Laboratory Procedure]
   748   C0751383:CLN3 [Disease or Syndrome]
   748   C1413495:CLN3 [Gene or Genome]
   748   C1704680:Staining [Finding]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]
Processing 00000000.tx.88: Overexpressed CLN3 protein is present in the neurites in beads-on-a-string fashion in contrast to uniform -tubulin staining (Fig. 4AC). 

Phrase: "Overexpressed CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "present in the neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in beads-on-a-string fashion"

Phrase: "in contrast to uniform -tubulin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(Fig. 4AC"

Phrase: ")."
Processing 00000000.tx.89: Partial co-localization of the human CLN3 with SV2 is very similar to that of the endogenous CLN3 (Fig. 4DF). 

Phrase: "Partial co-localization of the human CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "with SV2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427005:SV2 [Gene or Genome]

Phrase: "is"

Phrase: "very similar to that of the endogenous CLN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 4DF"

Phrase: ")."
Processing 00000000.tx.90: However, the CLN3-SV2 double immunostaining is not completely overlapping suggesting that these proteins are not found entirely in the same subcellular compartment. 

Phrase: "However,"

Phrase: "the CLN3-SV2 double immunostaining"

Phrase: "is"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "overlapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:Overlapping [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlapping [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "entirely in the same subcellular compartment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0445247:Same [Qualitative Concept]
   753   C1185625:Compartment [Body Space or Junction]
   753   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.91: With the lysosomal marker Lamp1 no significant co-localization was found (Fig. 4GI). 

Phrase: "With the lysosomal marker Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1416788:LAMP1 [Gene or Genome]
   827   C3540818:LAMP-1 [Gene or Genome]

Phrase: "no significant co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(Fig. 4GI"

Phrase: ")."
Processing 00000000.tx.92: View larger version (46K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.93: Confocal immunofluorescence analysis of SFV-mediated human CLN3 and subcellular markers in mouse retinal neurons. 

Phrase: "Confocal immunofluorescence analysis of SFV-mediated human CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "subcellular markers in mouse retinal neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.94: In the double immunostaining, CLN3 was stained with the polyclonal rabbit antibody against human CLN3 (h385/CLN3) (red) and subcellular markers with monoclonal mouse antibodies for -tubulin, SV2 and rat anti-Lamp1 antibody (green). 

Phrase: "In the double immunostaining,"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "was"

Phrase: "stained with the polyclonal rabbit antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034493:Rabbit [Mammal]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "against human CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751383:CLN3 [Disease or Syndrome]
   861   C1413495:CLN3 [Gene or Genome]

Phrase: "(h385/CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751383:CLN3 [Disease or Syndrome]
   861   C1413495:CLN3 [Gene or Genome]

Phrase: ")"

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "subcellular markers with monoclonal mouse antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0005516:Marker [Clinical Attribute]

Phrase: "for -tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "SV2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427005:SV2 [Gene or Genome]

Phrase: "and"

Phrase: "rat anti-Lamp1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.95: (A) CLN3 is present in the neurites in a beads-on-a-string fashion. 

Phrase: "(A) CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0751383:CLN3 [Disease or Syndrome]
   861   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "present in the neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in a beads-on-a-string fashion."
Processing 00000000.tx.96: (B) -Tubulin staining of the same field as (A). 

Phrase: "(B) -Tubulin staining of the same field as (A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: ")."
Processing 00000000.tx.97: (C) Superimposition of (A) and (B) show partial overlapping in the neuron (yellow). 

Phrase: "(C) Superimposition of ("

Phrase: "A)"

Phrase: "and ("

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "partial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728938:Partial [Quantitative Concept]
  1000   C1550516:partial [Idea or Concept]

Phrase: "overlapping in the neuron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neuron [Cell]
   770   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   770   C1948020:Overlapping [Conceptual Entity]

Phrase: "(yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.98: (D) CLN3 immunostaining. 

Phrase: "("

Phrase: "D)"

Phrase: "CLN3 immunostaining."
Processing 00000000.tx.99: (E) SV2 immunostaining of the same field as (D). 

Phrase: "(E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "SV2 immunostaining of the same field as ("

Phrase: "D)."
Processing 00000000.tx.100: (F) Superimposition of (D) and (E) show partial co-localization of overexpressed human CLN3 and the presynaptic marker SV2 (arrowheads). 

Phrase: "(F) Superimposition of ("

Phrase: "D)"

Phrase: "and ("

Phrase: "E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "partial co-localization of overexpressed human CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "the presynaptic marker SV2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1427005:SV2 [Gene or Genome]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.101: (GI) Staining for CLN3 and Lamp1 and the superimposition, respectively. 

Phrase: "(GI) Staining for CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416788:LAMP1 [Gene or Genome]
  1000   C3540818:LAMP-1 [Gene or Genome]

Phrase: "and"

Phrase: "the superimposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0429562:Superimposition [Finding]

Phrase: "respectively."
Processing 00000000.tx.102: No obvious co-localization with CLN3 and Lamp-1 is seen. 

Phrase: "No obvious co-localization with CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "Lamp-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3540818:LAMP-1 [Gene or Genome]
   861   C0392223:Lamp [Manufactured Object]
   861   C1705111:Lamp [Medical Device]
   861   C3539922:LAMP [Laboratory Procedure]

Phrase: "is"

Phrase: "seen."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]
Processing 00000000.tx.103: Scale bar: (AC) and (GH) 15 m; 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "(AC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "and ("

Phrase: "GH) 15 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.104: (DF) 20 m.  

Phrase: "(DF) 20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.105: Mouse brain tissue fractionation demonstrates synaptosomal localization of CLN3 Immunofluorescence studies with confocal microscopy revealed that CLN3 is present along the neuronal extensions and partially co-localizes with the presynaptic marker SV2. 

Phrase: "Mouse brain tissue fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016640:fractionation [Laboratory Procedure]
   812   C0524811:fractionation [Therapeutic or Preventive Procedure]
   812   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "demonstrates"

Phrase: "synaptosomal localization of CLN3 Immunofluorescence studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "with confocal microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "present along the neuronal extensions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "partially"

Phrase: "co-localizes with the presynaptic marker SV2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0005516:Marker [Clinical Attribute]
   748   C0392752:localize [Spatial Concept]
   748   C1427005:SV2 [Gene or Genome]
Processing 00000000.tx.106: We have recently demonstrated that PPT1, involved in the pathogenesis of the infantile form of NCL, is localized in the synaptic vesicle fraction (15). 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that PPT1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0380804:palmitoyl-protein thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418854:PALMITOYL-PROTEIN THIOESTERASE [Gene or Genome]
   913   C0030238:Palmitoyl Thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in the pathogenesis of the infantile form of NCL,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0027964:NCL [Geographic Area]
   739   C0231330:Infantile [Temporal Concept]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C0543483:pathogenesis [Functional Concept]
   739   C0699748:Pathogenesis [Pathologic Function]
   739   C1314939:Involved [Functional Concept]
   739   C1417613:NCL [Gene or Genome]
   739   C1522492:Form [Functional Concept]
   739   C2939166:Infantile [Qualitative Concept]

Phrase: "is"

Phrase: "localized in the synaptic vesicle fraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039065:Synaptic vesicle [Cell Component]
   753   C0333262:Vesicle [Acquired Abnormality]
   753   C0392752:Localized [Spatial Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1622418:vesicle [Cell Component]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.107: To further explore the localization of neuronal CLN3, a systematic subcellular fractionation of mouse brain tissue was performed. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "explore"

Phrase: "the localization of neuronal CLN3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "a systematic subcellular fractionation of mouse brain tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1656251:subcellular fractionation [Laboratory Procedure]
   744   C0016640:fractionation [Laboratory Procedure]
   744   C0524811:fractionation [Therapeutic or Preventive Procedure]
   744   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.108: Abundant CLN3 immunoreactivity was detected in the 1000 g postnuclear supernatant (PNS) and in the 14 500 g supernatant (S1) (Fig.5A). 

Phrase: "Abundant CLN3 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected in the 1000 g postnuclear supernatant (PNS)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439267:g% [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1550101:Supernatant [Body Substance]

Phrase: "and in the 14 500 g supernatant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439267:g% [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1550101:Supernatant [Body Substance]

Phrase: "(S1) (Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.109: A significant fraction of the CLN3 protein was also present in the 14 500 g pellet (P1). 

Phrase: "A significant fraction of the CLN3 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "present in the 14 500 g pellet"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0150312:Present [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0441436:Pellet [Manufactured Object]
   748   C0449450:Present [Idea or Concept]
   748   C0993610:Pellet [Biomedical or Dental Material]
   748   C1998480:Pellet [Quantitative Concept]

Phrase: "(P1"

Phrase: ")."
Processing 00000000.tx.110: The S1 fraction was further subjected to 100 000 g centrifugation after which a major portion of the CLN3 protein was detected in the pellet (P2). 

Phrase: "The S1 fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "subjected to 100 000 g centrifugation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007703:Centrifugation [Laboratory Procedure]
   753   C0439267:g% [Quantitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "after which"

Phrase: "a major portion of the CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "detected in the pellet"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441436:Pellet [Manufactured Object]
   770   C0442726:Detected [Finding]
   770   C0993610:Pellet [Biomedical or Dental Material]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1998480:Pellet [Quantitative Concept]

Phrase: "(P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.111: The crude synaptosomal fraction (P1) was purified by a discontinuous sucrose gradient to obtain the synaptosomal fraction (S) (Fig. 5B). 

Phrase: "The crude synaptosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "(P1)"

Phrase: "was"

Phrase: "purified by a discontinuous sucrose gradient to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0439599:Discontinuous [Temporal Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   748   C1444662:Discontinuous [Finding]
   748   C1998793:Purified [Functional Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the synaptosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039067:Synaptosomes [Cell Component]

Phrase: ")"

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.112: SVs were also purified from the synaptosomal fraction. 

Phrase: "SVs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039065:Synaptic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "purified from the synaptosomal fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1998793:Purified [Functional Concept]
Processing 00000000.tx.113: Western blot analysis indicated that CLN3 is present in the purified synaptosomal fraction but virtually no CLN3 protein can be detected in the synaptic vesicle fraction where the organelle marker synaptophysin was enriched. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "present in the purified synaptosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "virtually"

Phrase: "no CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "detected in the synaptic vesicle fraction where"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0039065:Synaptic vesicle [Cell Component]
   748   C0333262:Vesicle [Acquired Abnormality]
   748   C0442726:Detected [Finding]
   748   C1264633:Fraction [Quantitative Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1554103:Fraction [Idea or Concept]
   748   C1622418:vesicle [Cell Component]

Phrase: "the organelle marker synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "was"

Phrase: "enriched."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0359583:enriched [Food]
Processing 00000000.tx.114: Synaptophysin was also found in P2 (Fig. 5A). 

Phrase: "Synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "found in P2 (Fig. 5A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0150312:Found [Quantitative Concept]
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
   760   C1384585:P2 [Immunologic Factor]
   760   C1419693:P2 [Gene or Genome]
   760   C1539372:p2 [Gene or Genome]
   760   C1553637:5a [Medical Device]
   726 E C0243095:Find [Finding]

Phrase: ")."
Processing 00000000.tx.115: Interestingly, synaptophysin and CLN3 were both found as a monomeric as well as a high-molecular weight complex in P2. 

Phrase: "Interestingly,"

Phrase: "synaptophysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "and"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "were"

Phrase: "both"

Phrase: "found as a monomeric"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "as well as"

Phrase: "a high-molecular weight complex in P2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.116: This may indicate that CLN3, like synaptophysin, forms SDS-resistant, insoluble complexes. 

Phrase: "This"

Phrase: "may"

Phrase: "indicate"

Phrase: "that CLN3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "like synaptophysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "SDS-resistant, insoluble complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.117: The lysosomal membrane protein Lamp1 showed different enrichment in the subcellular fractionation compared with CLN3, as most of the lysosomal protein resided in P1. 

Phrase: "The lysosomal membrane protein Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1416788:LAMP1 [Gene or Genome]
   812   C3540818:LAMP-1 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "different enrichment in the subcellular fractionation"

Phrase: "compared with CLN3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0751383:CLN3 [Disease or Syndrome]
   790   C1413495:CLN3 [Gene or Genome]
   790   C1707455:Compared [Activity]

Phrase: "as"

Phrase: "most of the lysosomal protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205393:Most [Quantitative Concept]
   760   C0521450:Lysosomal [Body Location or Region]

Phrase: "resided in P1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2982691:Reside [Activity]
Processing 00000000.tx.118: The lysosomal proteins could be found enriched in the Percoll step gradient for lysosomes and CLN3 protein was present to a lesser extent in the lysosomal fraction (L, Fig. 5C). 

Phrase: "The lysosomal proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0065400:lysosomal proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "enriched in the Percoll step gradient"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0359583:enriched [Food]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1261552:Step [Conceptual Entity]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C2825408:Step [Manufactured Object]

Phrase: "for lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "present to a lesser extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "in the lysosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fig. 5C"

Phrase: ")."
Processing 00000000.tx.119: View larger version (41K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.120: Western blot analysis of subcellular fractions of mouse brain. 

Phrase: "Western blot analysis of subcellular fractions of mouse brain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]
Processing 00000000.tx.121: CLN3 immunostaining was performed with the m385/CLN3 antiserum and immunostainings for SYP and Lamp1 were performed with the respective monoclonal mouse and rat antibodies. 

Phrase: "CLN3 immunostaining"

Phrase: "was"

Phrase: "performed with the m385/CLN3 antiserum"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0751383:CLN3 [Disease or Syndrome]
   753   C0884358:Performed [Functional Concept]
   753   C1413495:CLN3 [Gene or Genome]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "immunostainings for SYP"

Phrase: "and"

Phrase: "Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416788:LAMP1 [Gene or Genome]
  1000   C3540818:LAMP-1 [Gene or Genome]

Phrase: "were"

Phrase: "performed with the respective monoclonal mouse"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0746619:monoclonal [Finding]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "rat antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.122: (A) Distribution of CLN3, Lamp1 and SYP immunostaining in the subcellular fractions PNS, S1, P1, S2 and P2 show that CLN3 (44 kDa) is divided into all fractions, the 110 kDa Lamp1 (79 kDa band is not specific) is mostly seen in the P1 and SYP is divided into all fractions, with the emphasis in PNS, P1 and P2. 

Phrase: "(A) Distribution of CLN3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416788:LAMP1 [Gene or Genome]
  1000   C3540818:LAMP-1 [Gene or Genome]

Phrase: "and"

Phrase: "SYP immunostaining in the subcellular fractions PNS,"

Phrase: "S1,"

Phrase: "P1,"

Phrase: "S2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: "and"

Phrase: "P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "(44 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "is"

Phrase: "divided into all fractions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332849:Divided [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "the 110 kDa Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1416788:LAMP1 [Gene or Genome]
   827   C3540818:LAMP-1 [Gene or Genome]

Phrase: "(79 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "not specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "seen in the P1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "and"

Phrase: "SYP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420554:SYP [Gene or Genome]

Phrase: "is"

Phrase: "divided into all fractions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332849:Divided [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "with the emphasis"

Phrase: "in PNS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "P1"

Phrase: "and"

Phrase: "P2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]
Processing 00000000.tx.123: (B) Comparison of CLN3 and SYP (38 kDa) in PNS, synaptosomes (S) and synaptic vesicles (SV) show that CLN3 is present in the synaptosomal fraction but absent from the synaptic vesicles, the same filter was also immunostained with the m385/CLN3 preimmune serum (control). 

Phrase: "(B) Comparison of CLN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "SYP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420554:SYP [Gene or Genome]

Phrase: "(38 kDa) in PNS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1532717:kDa [Quantitative Concept]

Phrase: "synaptosomes (S)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039067:Synaptosomes [Cell Component]

Phrase: "and"

Phrase: "synaptic vesicles (SV)"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039065:Synaptic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "present in the synaptosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "absent from the synaptic vesicles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "the same filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0180860:Filter [Manufactured Object]
   861   C0581406:Filter [Medical Device]
   861   C1522664:Filter [Intellectual Product]
   861   C1704449:Filter [Conceptual Entity]
   861   C1704684:Filter [Medical Device]
   861   C1875155:FILTER [Medical Device]

Phrase: "was"

Phrase: "also"

Phrase: "immunostained with the m385/CLN3 preimmune serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0229671:Serum [Body Substance]
   748   C0751383:CLN3 [Disease or Syndrome]
   748   C1413495:CLN3 [Gene or Genome]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.124: (C) Comparison of CLN3 and Lamp1 in the isolated lysosomes show enrichment of Lamp1 but not of CLN3.  

Phrase: "(C) Comparison of CLN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "Lamp1 in the isolated lysosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1416788:LAMP1 [Gene or Genome]
   760   C3540818:LAMP-1 [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "enrichment of Lamp1"

Phrase: "but"

Phrase: "not of CLN3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0751383:CLN3 [Disease or Syndrome]
   790   C1413495:CLN3 [Gene or Genome]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.125: Western blot analysis of the mouse brain pelleting experiments showed the different distribution pattern of CLN3 and Lamp1. 

Phrase: "Western blot analysis of the mouse brain pelleting experiments"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the different distribution pattern of CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449775:Distribution pattern [Spatial Concept]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "Lamp1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416788:LAMP1 [Gene or Genome]
  1000   C3540818:LAMP-1 [Gene or Genome]
Processing 00000000.tx.126: Remarkably, CLN3 is not identical to SYP either. 

Phrase: "Remarkably,"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "not identical to SYP either."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.127: Further fractionation studies of adult mice showed that CLN3 protein is present in the PNS and in the synaptosomal fraction. 

Phrase: "Further fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "studies of adult mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0001675:Adult [Age Group]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1706450:Adult [Human]
   770   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "present in the PNS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and in the synaptosomal fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.128: In the SVs and lysosomes CLN3 protein was not enriched as compared to PNS. 

Phrase: "In the SVs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039065:Synaptic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "lysosomes CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enriched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0359583:enriched [Food]

Phrase: "as"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "to PNS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.129: This indicates that CLN3 is not solely a lysosomal protein but has a yet unknown function at the neuronal synapses.  

Phrase: "This"

Phrase: "indicates"

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "not solely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "a lysosomal protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "has"

Phrase: "a yet unknown function at the neuronal synapses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
Processing 00000000.tx.130: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  In order to unravel the puzzle of the function for the CLN3 protein defective in Batten disease, it is crucial to investigate its role in the nervous system. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES  In order to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C1554218:references order [Idea or Concept]
   770   C1514811:Reference [Idea or Concept]
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1706462:Reference [Conceptual Entity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "unravel"

Phrase: "the puzzle of the function"

Phrase: "for the CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "defective in Batten disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "crucial to"

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "its role in the nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.131: As blindness is the first symptom and common to all Batten disease patients (6,16), retinal cell cultures provide an excellent research model. 

Phrase: "As blindness"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0456909:Blindness [Disease or Syndrome]
   928 E C0150108:Blind [Research Activity]
   928 E C0525065:blind [Patient or Disabled Group]

Phrase: "is"

Phrase: "the first symptom"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1457887:Symptom, NOS [Sign or Symptom]

Phrase: "and"

Phrase: "common to all Batten disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "(6,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "retinal cell cultures"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0007585:Cell Cultures [Laboratory Procedure]
   901   C2338017:Retinal cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0010453:Cultures [Idea or Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an excellent research model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0699956:research model [Intellectual Product]
   827   C3161035:Model [Intellectual Product]
Processing 00000000.tx.132: Co-localization with -tubulin indicates that CLN3 is expressed particularly in neural cells. 

Phrase: "Co-localization with -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "indicates"

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "expressed"

Phrase: "particularly in neural cells."
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   816   C0027882:Neural cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0599851:Neural [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   715 E C0027740:Nerve [Tissue]
   715 E C0027757:NERVE [Tissue]
   715 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.133: In addition, both immunofluorescence and mouse tissue fractionation studies clearly associate CLN3 protein with the presynaptic terminals and synaptosomes within the neural cells. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "both immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "mouse tissue fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016640:fractionation [Laboratory Procedure]
   827   C0524811:fractionation [Therapeutic or Preventive Procedure]
   827   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "clearly"

Phrase: "associate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "CLN3 protein with the presynaptic terminals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "synaptosomes within the neural cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0039067:Synaptosomes [Cell Component]
Processing 00000000.tx.134: This is in contrast to previous studies in non-neural cells, in which CLN3 was found mainly in the early and late endosomes and lysosomes (9 and unpublished data). 

Phrase: "This"

Phrase: "is in contrast to previous studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0205156:Previous [Temporal Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1552607:previous [Temporal Concept]
   753   C1979874:Contrast [Qualitative Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "in non-neural cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0027882:Neural cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in which CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "mainly in the early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1166848:late endosome [Cell Component]
   861   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(9"

Phrase: "and"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.135: Lysosomes of neural cells have been detected mainly in the cell soma where they form a very distinct punctuate pattern in contrast to CLN3 that is mainly detected in SVs along the neural extensions. 

Phrase: "Lysosomes of neural cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0024369:Lysosomes [Cell Component]
   737 E C2984253:Lysosome [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "mainly in the cell soma where"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0599444:Cell soma [Cell Component]
           soma
   790   C2752549:cell soma [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   737 E C1257909:Somatic cell [Cell]

Phrase: "they"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a very distinct"

Phrase: "punctuate"

Phrase: "pattern in contrast to CLN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "mainly"

Phrase: "detected in SVs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0039065:Synaptic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1622418:vesicle [Cell Component]

Phrase: "along the neural extensions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0231448:extensions [Functional Concept]
   827 E C1880641:Extension [Conceptual Entity]
Processing 00000000.tx.136: In the retinal neurons CLN3 was seen to accumulate in similar neuronal varicosities as GAP-43, indicating possible axonal targeting. 

Phrase: "In the retinal neurons CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0751383:CLN3 [Disease or Syndrome]
   827   C1413495:CLN3 [Gene or Genome]
   734   C2350331:Retinal Neurons [Cell]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate in similar neuronal varicosities"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0042345:Varicosities [Disease or Syndrome]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C2348205:Similar [Qualitative Concept]
   726 E C1527009:varicosity [Cell]

Phrase: "as GAP-43,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220844:growth [Physiologic Function]
   812   C0332281:Associated [Qualitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "indicating"

Phrase: "possible axonal targeting."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1521840:Targeting [Functional Concept]
   793 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.137: The specific targeting of CLN3 to neurites might indicate that CLN3 is involved in the neuronal endocytosis or exocytosis. 

Phrase: "The specific targeting of CLN3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1521840:Targeting [Functional Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "to neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085103:Neurites [Cell Component]

Phrase: "might"

Phrase: "indicate"

Phrase: "that CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "involved in the neuronal endocytosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014139:Endocytosis [Cell Function]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1314939:Involved [Functional Concept]
   760   C2984285:Endocytosis [Functional Concept]

Phrase: "or"

Phrase: "exocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.138: However, CLN3 is not enriched in the actual SVs suggesting its role to be different from synaptic vesicle membrane proteins. 

Phrase: "However,"

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enriched in the actual SVs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0039065:Synaptic Vesicles [Cell Component]
   753   C0237400:Actual [Qualitative Concept]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C0359583:enriched [Food]
   719 E C1622418:vesicle [Cell Component]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "its role to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "be"

Phrase: "different from synaptic vesicle membrane proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.139: Pelleting of the mouse brain PNS demonstrated that unlike the lysosomal membrane protein Lamp1, CLN3 is present, apart from the isolated synaptosomes, in both 100000g pellet (P2) and supernatant (S2). 

Phrase: "Pelleting of the mouse brain PNS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0441436:pelleting [Manufactured Object]
   748   C0993610:pelleting [Biomedical or Dental Material]
   714 E C1998480:Pellet [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "that unlike the lysosomal membrane protein Lamp1,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0230812:Lysosomal membrane [Cell Component]
   774   C0125271:LAMP1 Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0025255:Membrane [Tissue]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0521450:Lysosomal [Body Location or Region]
   748   C0596901:Membrane [Cell Component]
   748   C1416788:LAMP1 [Gene or Genome]
   748   C1706182:Membrane [Manufactured Object]
   748   C3540818:LAMP-1 [Gene or Genome]

Phrase: "CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: "is"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "apart from the isolated synaptosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039067:Synaptosomes [Cell Component]

Phrase: "in both 100000g pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "(P2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "and"

Phrase: "supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(S2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.140: This finding indicates its presence also in some yet unidentified microvesicular compartment. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "indicates"

Phrase: "its presence also in some yet unidentified microvesicular compartment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.141: The absence of CLN3 protein from SVs but its presence in the synaptosomes and microvesicles may indicate a circulating role, which is further supported by the previous findings of CLN3 residing in several different subcellular compartments in non-neuronal cells (912). 

Phrase: "The absence of CLN3 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "from SVs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039065:Synaptic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "but"

Phrase: "its presence in the synaptosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "microvesicles"

Phrase: "may"

Phrase: "indicate"

Phrase: "a circulating role,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by the previous findings of CLN3 residing"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   744   C0205156:Previous [Temporal Concept]
   744   C0751383:CLN3 [Disease or Syndrome]
   744   C1413495:CLN3 [Gene or Genome]
   744   C1521721:Supported [Conceptual Entity]
   744   C1552607:previous [Temporal Concept]
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0183683:Support [Medical Device]
   711 E C0243095:Finding [Finding]
   711 E C2825141:Finding [Finding]
   711   C2982691:Reside [Activity]

Phrase: "in several different subcellular compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1185625:Compartments [Body Space or Junction]
   812   C1382196:Compartments [Natural Phenomenon or Process]
   779 E C2986730:Compartment [Spatial Concept]

Phrase: "in non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(912"

Phrase: ")."
Processing 00000000.tx.142: One possible function of CLN3 protein could be transporting some cargo to be delivered to the SVs. 

Phrase: "One possible function of CLN3 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "transporting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005528:Transport, NOS [Cell Function]
   966   C1317949:Transport [Manufactured Object]
   966   C3495449:transport [Medical Device]

Phrase: "some cargo to"

Phrase: "be"

Phrase: "delivered to the SVs."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0039065:Synaptic Vesicles [Cell Component]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C1705822:Delivered [Activity]
   726 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   726 E C1622418:vesicle [Cell Component]
   726 E C1874964:DELIVER [Pharmacologic Substance]
Processing 00000000.tx.143: The biogenesis of SVs through the endosomal AP3 mediated pathway has only recently been demonstrated (17). 

Phrase: "The biogenesis of SVs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005495:Biogenesis [Natural Phenomenon or Process]
   760   C0220781:Biogenesis [Biologic Function]

Phrase: "through the endosomal AP3"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "has"

Phrase: "only recently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.144: This pathway contains a bulk of yet unidentified protein components. 

Phrase: "This pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a bulk of yet unidentified protein components."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0012173:Bulk [Food]
   748   C1337615:Bulk [Biomedical or Dental Material]
Processing 00000000.tx.145: Steps toward understanding the exact routing of CLN3 could be taken by exploring the potential sorting signals within CLN3 protein. 

Phrase: "Steps toward understanding"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1261552:steps [Conceptual Entity]
   756 E C1704379:Step [Functional Concept]
   756 E C1705117:Step [Quantitative Concept]
   756 E C2825408:Step [Manufactured Object]

Phrase: "the exact routing of CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0013153:ROUTE [Functional Concept]
   726   C0449444:Route [Spatial Concept]
   726   C1879941:ROUTE [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "taken by exploring"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "the potential sorting signals within CLN3 protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0887827:Protein Sorting Signals [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.146: There is a putative farnesylation motif CQLS in the C-terminus, which does not appear to affect the targeting of the CLN3 (18). 

Phrase: "There"

Phrase: "is"

Phrase: "a putative farnesylation motif CQLS in the C-terminus,"

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the targeting of the CLN3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1521840:Targeting [Functional Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.147: C-terminus of CLN3 at amino acids 425 and 426 also contains a dileucine lysosomal targeting motif, which does not seem to be functional either (10). 

Phrase: "C-terminus of CLN3"

Phrase: "at amino acids 425"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "426 also"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a dileucine lysosomal targeting motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "functional either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205245:Functional [Functional Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.148: Furthermore, a tyrosine-based targeting motif YXX (Y is tyrosine, X any amino acid, an amino acid with a bulky hydrophobic side chain) is present in CLN3; 

Phrase: "Furthermore,"

Phrase: "a tyrosine-based targeting motif YXX"

Phrase: "(Y"

Phrase: "is"

Phrase: "tyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "X"

Phrase: "any amino acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "an amino acid with a bulky hydrophobic side chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "is"

Phrase: "present in CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.149: however, so far it has not been demonstrated to be functional. 

Phrase: "however,"

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "it"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "functional."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.150: Tyrosine-based sorting signals have several known functions; 

Phrase: "Tyrosine-based sorting signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "have"

Phrase: "several known functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.151: mediating rapid internalization from the cell surface, lysosomal targeting, localization to specialized endosomallysosomal organelles, delivery to the basolateral plasma membrane of polarised epithelial cells or transport to SVs (19). 

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "rapid internalization from the cell surface,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0871786:internalization [Mental Process]

Phrase: "lysosomal targeting,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521840:Targeting [Functional Concept]
   827 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "localization to specialized endosomallysosomal organelles,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1660641:organelle localisation [Biologic Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "delivery to the basolateral plasma membrane of polarised epithelial cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0011209:Delivery [Therapeutic or Preventive Procedure]
   739   C0559563:delivery [Finding]
   739   C1705822:Delivery [Activity]

Phrase: "or"

Phrase: "transport to SVs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   865   C1154481:synaptic vesicle transport [Cell Function]
   833   C1550030:Transport To [Idea or Concept]
   819   C0887882:Transport Vesicles [Cell Component]
   802 E C1325417:vesicle transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.152: It will be of great interest to investigate whether CLN3 protein interacts with the AP3 coat. 

Phrase: "It"

Phrase: "will"

Phrase: "be of great interest to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0543488:Interest [Mental Process]
   760   C0549177:Great [Quantitative Concept]
   760   C1704243:Great [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "CLN3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with the AP3 coat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0453946:Coat [Manufactured Object]
   760   C1522408:Coat [Qualitative Concept]
   760   C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.153: In comparison, PPT1 mutated in the infantile form of NCL has been reported to be present in the neurites and localized in synaptosomes as well as in the actual SVs (15). 

Phrase: "In comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "PPT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0380804:palmitoyl-protein thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418854:PALMITOYL-PROTEIN THIOESTERASE [Gene or Genome]
   913   C0030238:Palmitoyl Thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mutated in the infantile form of NCL"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0027964:NCL [Geographic Area]
   748   C0231330:Infantile [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1417613:NCL [Gene or Genome]
   748   C1522492:Form [Functional Concept]
   748   C1705285:Mutated [Cell or Molecular Dysfunction]
   748   C2939166:Infantile [Qualitative Concept]
   714 E C1513776:Mutate [Genetic Function]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in the neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "localized in synaptosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0039067:Synaptosomes [Cell Component]
   790   C0392752:Localized [Spatial Concept]

Phrase: "as well as in the actual SVs"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0039065:Synaptic Vesicles [Cell Component]
   744   C0205170:Well [Qualitative Concept]
   744   C0237400:Actual [Qualitative Concept]
   744   C0333262:VESICLES [Acquired Abnormality]
   744   C3146287:Well [Manufactured Object]
   711 E C1622418:vesicle [Cell Component]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.154: In peripheral cells PPT1 is localized in the lysosomes (15,20) and, analogously to CLN3, this NCL protein has a different localization in neuronal cells. 

Phrase: "In peripheral cells PPT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0380804:palmitoyl-protein thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1418854:PALMITOYL-PROTEIN THIOESTERASE [Gene or Genome]
   853   C0030238:Palmitoyl Thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "localized in the lysosomes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0024369:Lysosomes [Cell Component]
   770   C0392752:Localized [Spatial Concept]
   737 E C2984253:Lysosome [Functional Concept]

Phrase: "(15,"

Phrase: "20"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "analogously to CLN3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0751383:CLN3 [Disease or Syndrome]
   790   C1413495:CLN3 [Gene or Genome]

Phrase: "this NCL protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "a different localization in neuronal cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1660153:cell localization [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.155: PPT1 has been closely connected to neuronal development and especially to synaptogenesis (21,22). 

Phrase: "PPT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0380804:palmitoyl-protein thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418854:PALMITOYL-PROTEIN THIOESTERASE [Gene or Genome]
   913   C0030238:Palmitoyl Thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "closely"

Phrase: "connected to neuronal development"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1657987:neuron development [Cell Function]
   770   C0243107:development [Physiologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   737   C2986575:Connect [Activity]

Phrase: "and"

Phrase: "especially to synaptogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597545:synaptogenesis [Organ or Tissue Function]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.156: Localization of other NCL proteins has been studied in non-neuronal cells as well and it has been reported that the protein encoded by the CLN2 gene is a lysosomal tripeptidyl peptidase (TTP1) (23). 

Phrase: "Localization of other NCL proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0597704:protein localisation [Cell Function]
   781   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "studied in non-neuronal cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   851   C0027836:Non-neuronal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1518422:Non [Functional Concept]
   760   C3282337:Cells [Cell]
   726   C0557651:Study [Manufactured Object]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C2603343:Study [Research Activity]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "encoded by the CLN2 gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1540042:CLN2 GENE [Gene or Genome]
           CLN2
   760   C0017337:Gene [Gene or Genome]
   760   C0679058:encoded [Mental Process]
   760   C1876161:CLN2 [Disease or Syndrome]
   760   C2700640:Encoded [Activity]

Phrase: "is"

Phrase: "a lysosomal tripeptidyl peptidase (TTP1)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0077246:Tripeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0661884:Tripeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1947941:Peptidase [Enzyme]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.157: In comparison, CLN8 is a membrane protein trafficking between the ER and Golgi intermediate compartment (24). 

Phrase: "In comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "CLN8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413500:CLN8 [Gene or Genome]
  1000   C1838570:CLN8 [Disease or Syndrome]

Phrase: "is"

Phrase: "a membrane protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0025255:Membrane [Tissue]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "trafficking between the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "Golgi intermediate compartment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1185625:Compartment [Body Space or Junction]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.158: It will be of great interest to see whether the trafficking of these proteins in neuronal cells is different from that in non-neuronal cells. 

Phrase: "It"

Phrase: "will"

Phrase: "be of great interest to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0543488:Interest [Mental Process]
   760   C0549177:Great [Quantitative Concept]
   760   C1704243:Great [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "whether"

Phrase: "the"

Phrase: "trafficking of these proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0599895:Protein Trafficking [Cell Function]
   802   C1159772:Protein Trafficking [Cell Function]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0599896:trafficking [Cell Function]

Phrase: "in neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "different from that"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "in non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.159: Eventually, the whole set of eight different NCL proteins may define some specific transport route in neurons. 

Phrase: "Eventually,"

Phrase: "the whole set of eight different NCL proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036849:Set [Mental Process]
   744   C1442518:Set [Functional Concept]
   744   C1705195:Set [Conceptual Entity]

Phrase: "may"

Phrase: "define"

Phrase: "some specific transport route in neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0013153:ROUTE [Functional Concept]
   753   C0449444:Route [Spatial Concept]
   753   C1879941:ROUTE [Intellectual Product]
Processing 00000000.tx.160: In terms of the brain pathology of Batten disease patients, documented early lesions are the loss of small stellate neurons in layer II and the loss of pyramidal neurons of layer V in the cerebral cortex (25,26). 

Phrase: "In terms of the brain pathology"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0006119:Brain Pathology [Pathologic Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "of Batten disease patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0751383:Batten Disease [Disease or Syndrome]

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "early lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "are"

Phrase: "the loss of small stellate neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   820   C0598940:Loss of neurons [Finding]
           neuron loss
   753   C1517945:Loss [Quantitative Concept]
   742 E C1850496:Neuronal loss [Finding]

Phrase: "in layer II"

Phrase: "and"

Phrase: "the loss of pyramidal neurons of layer V"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0598940:Loss of neurons [Finding]
           neuron loss
   744   C1517945:Loss [Quantitative Concept]
   725 E C1850496:Neuronal loss [Finding]

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.161: Immunohistochemistry of mouse brain sections also showed a prominent staining of CLN3 in the hippocampus and cerebellum. 

Phrase: "Immunohistochemistry of mouse brain sections also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a prominent staining of CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.162: Nonetheless, more thorough characterization of neurodegeneration of these areas in Batten patients has not been conducted. 

Phrase: "Nonetheless,"

Phrase: "more thorough characterization of neurodegeneration of these areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "in Batten patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "conducted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]
Processing 00000000.tx.163: Our current results indicate that synapses might be an important site of pathology; 

Phrase: "Our current results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that synapses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0039062:Synapses [Body Space or Junction]
   966 E C0598501:Synapsis [Cell Function]
   966 E C1633000:Synapsis [Plant]

Phrase: "might"

Phrase: "be"

Phrase: "an important site of pathology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.164: however, analysis of the synapses in Batten disease patients has not been documented either. 

Phrase: "however,"

Phrase: "analysis of the synapses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in Batten disease patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0751383:Batten Disease [Disease or Syndrome]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "either."
Processing 00000000.tx.165: In a canine model of juvenile Batten disease, loss of GABAergic neurons and synapses in the cortex and cerebellum of affected dogs is demonstrated (27). 

Phrase: "In a canine model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of juvenile Batten disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0751383:Juvenile Batten Disease [Disease or Syndrome]
           Batten Disease
   913   C0277561:Juvenile disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "loss of GABAergic neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   881   C0598940:Loss of neurons [Finding]
           neuron loss
   777 E C1850496:Neuronal loss [Finding]
   770   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "synapses in the cortex"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0039062:Synapses [Body Space or Junction]
   737 E C0598501:Synapsis [Cell Function]
   737 E C1633000:Synapsis [Plant]

Phrase: "and"

Phrase: "cerebellum of affected dogs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1707522:Cerebellum [Tissue]

Phrase: "is"

Phrase: "demonstrated"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.166: Synaptic function is very sensitive to alterations in the levels of receptors, ion channels and transporters, and an accumulation of abnormal or mistargeted proteins at the synaptic site might be responsible for neurodysfunction and neurodegeneration. 

Phrase: "Synaptic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "very sensitive to alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332324:Sensitive to [Functional Concept]
           Sensitive
   770   C1550474:sensitive [Idea or Concept]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "ion channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "transporters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "an accumulation of abnormal"

Phrase: "or"

Phrase: "mistargeted proteins at the synaptic site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "be"

Phrase: "responsible for neurodysfunction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.167: This is well exemplified in Alzheimers disease, where a decrease in synaptic density can be demonstrated (28). 

Phrase: "This"

Phrase: "is"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "exemplified in Alzheimers disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "where"

Phrase: "a decrease in synaptic density"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "demonstrated"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.168: Recently, a Cln3-deficient mouse model for studying Batten disease has been developed (29) and it will be of great interest to analyse the possible defect in the endocytic pathway of the Batten mouse neurons. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a Cln3-deficient mouse model for studying Batten disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C2986594:Mouse Model [Experimental Model of Disease]
   762   C0683033:disease model [Intellectual Product]
   762   C0684309:Disease model [Experimental Model of Disease]
   742   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "developed"

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "it"

Phrase: "will"

Phrase: "be of great interest to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0543488:Interest [Mental Process]
   760   C0549177:Great [Quantitative Concept]
   760   C1704243:Great [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "analyse"

Phrase: "the possible defect in the endocytic pathway of the Batten mouse neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1457869:Defect [Functional Concept]
   736   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.169: Involvement of the endocytic pathway in Batten disease has also been implicated by studies using the yeast knockout model for the CLN3 homologue BTN1p. 

Phrase: "Involvement of the endocytic pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in Batten disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0751383:Batten Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "implicated by studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast knockout model for the CLN3 homologue BTN1p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1520210:Yeast Model [Research Activity]
   742   C3161035:Model [Intellectual Product]
Processing 00000000.tx.170: In yeast, an absence of BTN1p causes changes in the expression profile of the endocytic HOOK protein and a change in the yeast vacuolar pH (8). 

Phrase: "In yeast,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "an absence of BTN1p causes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "changes in the expression profile of the endocytic HOOK protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   777   C3463810:protein expression profile [Laboratory or Test Result]
   757   C1171362:expression protein [Genetic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0181209:Hook [Medical Device]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]
   739   C1979963:Profile [Laboratory Procedure]
   739   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "a change in the yeast vacuolar pH (8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.171: This observation together with the novel synaptosomal localization finding direct the functional analysis of protein away from the lysosomes towards the endocytic and exocytic neuronal transport pathways. 

Phrase: "This observation together with the novel synaptosomal localization finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0302523:Observation [Research Activity]
   742   C0700325:observation [Health Care Activity]
   742   C1964257:Observation [Diagnostic Procedure]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "the functional analysis of protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0558024:Functional analysis [Health Care Activity]
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "away from the lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "towards the endocytic"

Phrase: "and"

Phrase: "exocytic neuronal transport pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C2984542:Transport Pathway [Functional Concept]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.172: Molecular alterations at the synapses of Batten knockout mice, such as analysing whether accumulation of synaptic proteins occur, should yield important clues toward the mechanisms of neurodegeneration or presynaptic damage in Batten disease.  

Phrase: "Molecular alterations at the synapses of Batten knockout mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1515926:Alteration [Idea or Concept]

Phrase: "such as analysing"

Phrase: "whether"

Phrase: "accumulation of synaptic proteins"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "should"

Phrase: "yield"

Phrase: "important clues toward the mechanisms of neurodegeneration"

Phrase: "or"

Phrase: "presynaptic damage in Batten disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]
Processing 00000000.tx.173: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Tissue preparation Tissue samples used were intracardially perfusion-fixed (4% PFA) and paraffin embedded 2.5-month-old mouse brain samples. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tissue preparation Tissue samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   886   C1292533:Tissue Sample [Tissue]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "intracardially perfusion-fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0231441:Fixed [Finding]
   827   C0443218:Fixed [Qualitative Concept]
   827   C2827483:Fixed [Body Substance]

Phrase: "(4% PFA)"

Phrase: "and"

Phrase: "paraffin embedded 2.5-month-old mouse brain samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C0370003:Sample [Substance]
   758   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.174: The tissue was cut into 5 m sections and mounted on a Super Frost (Menzel Glzer) objective glass. 

Phrase: "The tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "cut into 5 m sections"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C1440942:M-5 [Immunologic Factor]
   760   C0000925:Cut [Injury or Poisoning]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1883724:CUT [Phenomenon or Process]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "mounted on a Super Frost"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449878:mounted [Finding]
   726 E C0181909:Mount [Medical Device]

Phrase: "(Menzel Glzer"

Phrase: ")"

Phrase: "objective glass."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017596:Glass [Manufactured Object]
   861   C1947936:Glass [Medical Device]
   789 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   789 E C0522500:Glassy [Qualitative Concept]
Processing 00000000.tx.175: In situ hybridization For the generation of probes, PCR fragment corresponding to nucleotides 262584 of the mouse Cln3 cDNA (EST AA274409) was cloned into pBluescript"II SK() vector (Stratagene). 

Phrase: "In situ hybridization For the generation of probes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   770   C0444498:In situ [Spatial Concept]
   744   C0020202:Hybridisation [Genetic Function]
   744   C1300517:Hybridization [Laboratory Procedure]

Phrase: "PCR fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to nucleotides 262584 of the mouse Cln3 cDNA (EST AA274409"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0025914:Mouse [Mammal]
   738   C0025929:mouse [Mammal]
   738   C0026809:Mouse [Mammal]
   738   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0751383:CLN3 [Disease or Syndrome]
   738   C1413495:CLN3 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "cloned into pBluescript""II SK() vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0009013:cloned [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.176: Digoxigenin (DIG)-labelled anti-sense and sense probes were generated using DIG RNA labelling kit (Boehringer Mannheim) according to the manufacturers instructions. 

Phrase: "Digoxigenin (DIG)-labelled anti-sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "sense probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DIG RNA labelling kit (Boehringer Mannheim"

Phrase: ")"

Phrase: "according to the manufacturers instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.177: The nucleotide sequences of the probes were confirmed by sequencing with ABI PRISM 377 (Applied Biosystems). 

Phrase: "The nucleotide sequences of the probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0004793:Sequences, Nucleotide [Nucleotide Sequence]
       E   Sequence
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "confirmed by sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "with ABI PRISM 377"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0814195:PRISM [Intellectual Product]
   827   C1328319:ABI [Clinical Attribute]
   771 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.178: Non-radioactive in situ hybridization was performed as described previously (30). 

Phrase: "Non-radioactive in situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.179: The sense probe was used as a negative control. 

Phrase: "The sense probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "used as a negative control."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.180: Antibodies The polyclonal rabbit h385/CLN3 antibody against a synthetic peptide corresponding to human amino acid sequence 242258 of the full-length CLN3 cDNA was produced as described previously (9). 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "The polyclonal rabbit h385/CLN3 antibody against a synthetic peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "corresponding to human amino acid sequence 242258 of the full-length CLN3 cDNA"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   766   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   750   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750   C2917660:Amino Acid [Pharmacologic Substance]
   735   C0001128:Acid [Chemical]
   735   C0004793:Sequence [Nucleotide Sequence]
   735   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   735   C0086418:Human [Human]
   735   C0162326:Sequence [Nucleotide Sequence]
   735   C0162327:Sequence [Nucleotide Sequence]
   735   C0202406:Acid [Laboratory Procedure]
   735   C0443225:Full [Qualitative Concept]
   735   C0751383:CLN3 [Disease or Syndrome]
   735   C1413495:CLN3 [Gene or Genome]
   735   C1444754:Length [Quantitative Concept]
   735   C1519249:Sequence [Functional Concept]
   735   C1706316:LENGTH [Research Activity]

Phrase: "was"

Phrase: "produced"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.181: A novel polyclonal rabbit antibody m385/CLN3 was produced against the corresponding mouse Cln3 amino acid sequence 242258 (Invitrogen). 

Phrase: "A novel polyclonal rabbit antibody m385/CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0751383:CLN3 [Disease or Syndrome]
   799   C1413495:CLN3 [Gene or Genome]

Phrase: "was"

Phrase: "produced against the corresponding mouse Cln3 amino acid sequence 242258"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   782   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0751383:CLN3 [Disease or Syndrome]
   739   C1413495:CLN3 [Gene or Genome]
   739   C1519249:Sequence [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.182: For rabbit immunizations, 500 g of peptide was emulsified in complete Freunds adjuvant and injected intradermally at multiple sites. 

Phrase: "For rabbit immunizations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0020971:Immunizations [Therapeutic or Preventive Procedure]
   827 E C0042196:immunization [Therapeutic or Preventive Procedure]
   827 E C3244291:immunization [Functional Concept]

Phrase: "500 g of peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "emulsified in complete Freunds adjuvant"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0016712:complete Freund's adjuvant [Immunologic Factor,Pharmacologic Substance]
           Freund's Adjuvant
           Complete adjuvant
   760   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   760   C0001552:Adjuvant [Chemical Viewed Functionally]
   760   C0205197:Complete [Qualitative Concept]
   760   C0725685:COMPLEAT [Food]
   760   C1522673:Adjuvant [Functional Concept]

Phrase: "and"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intradermally at multiple sites."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205145:Sites [Spatial Concept]
   770   C0439064:Multiple [Quantitative Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.183: Injections were performed at 3 week intervals for total of 9weeks. 

Phrase: "Injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "were"

Phrase: "performed at 3 week intervals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0332174:/week [Temporal Concept]
   760   C0439230:week [Temporal Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1272706:intervals [Temporal Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of 9weeks."
Processing 00000000.tx.184: The antiserum was tested by immunofluorescence staining of CLN3-transfected COS-1 and HeLa cells. 

Phrase: "The antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "tested by immunofluorescence staining of CLN3-transfected COS-1"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   764   C0376702:COS-1 [Cell]
   742   C0016318:Immunofluorescence [Laboratory Procedure]
   742   C0079603:Immunofluorescence [Laboratory Procedure]
   742   C0392366:tested [Intellectual Product]
   742   C0454802:Cos [Geographic Area]
   742   C0487602:Staining [Laboratory Procedure]
   742   C0751383:CLN3 [Disease or Syndrome]
   742   C1413495:CLN3 [Gene or Genome]
   742   C1704680:Staining [Finding]
   708 E C0022885:Test [Laboratory Procedure]
   708 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "HeLa cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.185: In addition, testing by western blot analysis of CLN3-transfected COS-1 cells was performed using the pre-immune serum as a negative control. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "testing by western blot analysis of CLN3-transfected COS-1 cells"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   775   C0949466:Western blot analysis [Laboratory Procedure]
           blot testing western
           Western Blot
   775   C1257857:COS-1 Cells [Cell]
   756   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   756   C0376702:COS-1 [Cell]
           COS Cells
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0007634:Cells [Cell]
   738   C0039593:Testing [Functional Concept]
   738   C0392366:testing [Intellectual Product]
   738   C0454802:Cos [Geographic Area]
   738   C0751383:CLN3 [Disease or Syndrome]
   738   C0936012:Analysis [Research Activity]
   738   C1413495:CLN3 [Gene or Genome]
   738   C1524024:analysis [Functional Concept]
   738   C1705493:Western [Spatial Concept]
   738   C3282337:Cells [Cell]
   704 E C0022885:Test [Laboratory Procedure]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the pre-immune serum as a negative control."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0229671:Serum [Body Substance]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
Processing 00000000.tx.186: Immunohistochemical staining After deparaffinization with xylene and decreasing graded series of ethanol solutions endogenous peroxidase activity was blocked with 5% H2O2 for 5 min. 

Phrase: "Immunohistochemical staining After deparaffinization"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1441616:Immunohistochemical [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with xylene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "decreasing graded series of ethanol solutions endogenous peroxidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205549:Series [Quantitative Concept]
   742   C2348044:Series [Intellectual Product]

Phrase: "was"

Phrase: "blocked with 5% H2O2"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.187: Unspecific binding was blocked with 10% fetal calf serum (FCS, Gibco-BRL) for 1 h. 

Phrase: "Unspecific binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked with 10% fetal calf serum"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0028778:Blocked [Pathologic Function]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0332206:Blocked [Functional Concept]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "(FCS,"

Phrase: "Gibco-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.188: Primary antiserum m385 was diluted in the blocking mixture (1:100) and the sections were incubated overnight at 4C. 

Phrase: "Primary antiserum m385"

Phrase: "was"

Phrase: "diluted in the blocking mixture"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0439962:Mixture [Substance]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "and"

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.189: Sections were washed four times with 1% FCS in Tris-buffered saline (TBS) and incubated with biotinylated goat anti-rabbit IgG (Vector; 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times with 1% FCS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in Tris-buffered saline (TBS)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "and"

Phrase: "incubated with biotinylated goat anti-rabbit IgG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0018019:goat [Mammal]
   748   C0034493:Rabbit [Mammal]
   748   C1265549:goat [Mammal]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1510458:Goat [Mammal]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.190: 1:200) for 1 h at room temperature, followed by incubation with peroxidase-conjugated avidinbiotin complex (Vectastain Standard ABC reagent, Vector, 1:200 in TBS) for 40 min. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with peroxidase-conjugated avidinbiotin complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Vectastain Standard ABC reagent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200 in TBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: "for 40 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.191: Specific binding was detected by using 0.05% 3,3'-diaminobenzidine (DAB Fast kit, Sigma) as the chromogen and 0.3% H2O2 as the substrate. 

Phrase: "Specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "detected by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.05% 3,"

Phrase: "3'-diaminobenzidine"

Phrase: "(DAB Fast kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0812225:KIT [Medical Device]
   827   C1150635:KIT [Molecular Function]
   827   C1705212:Kit [Medical Device]
   827   C1705213:KIT [Medical Device]
   827   C3273202:Kit [Manufactured Object]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "as the chromogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052799:Chromogen [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "0.3% H2O2 as the substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.192: Counterstain was produced by Mayers hemalum solution (Merck) and 0.75% NH3. 

Phrase: "Counterstain"

Phrase: "was"

Phrase: "produced by Mayers hemalum solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0065758:Mayers's hemalum [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(Merck"

Phrase: ")"

Phrase: "and"

Phrase: "0.75% NH3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201879:NH3 [Laboratory Procedure]
Processing 00000000.tx.193: Dissection and culturing of retinal neurons Retinal neuron cultures were prepared from 14.517.5-day-old mouse embryos (E14.517.5 C57BL) as follows: the eyes were removed and transferred into ice-cold 0.1 M phosphate-buffered saline (PBS) without Ca2+ and Mg2+ pH 7.4, supplemented with 20 mM glucose and incubated at 37C for 20 min in order to weaken cation-dependent interactions between the retina and the retinal pigment epithelium. 

Phrase: "Dissection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "culturing of retinal neurons Retinal neuron cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from 14.517.5-day-old mouse embryos"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   742   C0013935:Embryos [Embryonic Structure]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0332173:/day [Temporal Concept]
   742   C0439228:day [Temporal Concept]
   742   C0439505:/day [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   708 E C1305370:Embryo [Embryonic Structure]
   708   C1521827:Prepare [Functional Concept]

Phrase: "(E14.517.5 C57BL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025921:C57BL [Mammal]

Phrase: ")"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "the eyes"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0015392:Eyes [Body Part, Organ, or Organ Component]
   966 E C1280202:Eye [Body Part, Organ, or Organ Component]
   928 E C0029144:optic [Occupation or Discipline]
   928 E C0042789:Ocular [Organism Function]
   928 E C1299003:Ocular [Spatial Concept]
   900 E C0014236:Ophthalmia [Disease or Syndrome]
   900 E C0700042:Oculus [Body Location or Region]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "transferred into ice-cold 0.1 M phosphate-buffered saline (PBS)"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   760   C0456963:Ice cold [Qualitative Concept]
   757   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0009264:Cold [Natural Phenomenon or Process]
   739   C0009443:Cold [Disease or Syndrome]
   739   C0020746:Ice [Inorganic Chemical]
   739   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   739   C0031701:phosphate [Organophosphorus Compound]
   739   C0036082:Saline [Substance]
   739   C0234192:Cold [Physiologic Function]
   739   C0348011:transferred [Functional Concept]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]
   739   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   706 E C0040671:Transfer [Mental Process]
   706 E C1705822:Transfer [Activity]

Phrase: "without Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "Mg2+ pH 7.4,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C2678549:PH-4 [Gene or Genome]
   861   C1882074:pH 7 [Qualitative Concept]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
   812   C1417500:MG2 [Gene or Genome]
   812   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "supplemented with 20 mM glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to"

Phrase: "weaken"

Phrase: "cation-dependent interactions between the retina"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the retinal pigment epithelium."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0035322:Retinal Pigment Epithelium [Body Part, Organ, or Organ Component]
   901   C0035323:retinal pigment [Biologically Active Substance,Organic Chemical]
   901   C1519082:Pigment Epithelium [Body Part, Organ, or Organ Component]
   827   C0014609:Epithelium [Tissue]
   827   C0031916:Pigment [Chemical Viewed Functionally]
   827   C0035298:Retinal [Body Part, Organ, or Organ Component]
   755 E C0221908:Epithelial [Qualitative Concept]
   755 E C0333610:Pigmented [Qualitative Concept]
Processing 00000000.tx.194: For each eye the retinal pigment epithelium and the vitreous humour were peeled away and the lens was removed. 

Phrase: "For each eye"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0015392:Eye [Body Part, Organ, or Organ Component]
  1000   C1280202:Eye [Body Part, Organ, or Organ Component]
   944 E C0029144:optic [Occupation or Discipline]
   944 E C0042789:Ocular [Organism Function]
   944 E C1299003:Ocular [Spatial Concept]
   907 E C0014236:Ophthalmia [Disease or Syndrome]
   907 E C0700042:Oculus [Body Location or Region]

Phrase: "the retinal pigment epithelium"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0035322:Retinal Pigment Epithelium [Body Part, Organ, or Organ Component]
   901   C0035323:retinal pigment [Biologically Active Substance,Organic Chemical]
   901   C1519082:Pigment Epithelium [Body Part, Organ, or Organ Component]
   827   C0014609:Epithelium [Tissue]
   827   C0031916:Pigment [Chemical Viewed Functionally]
   827   C0035298:Retinal [Body Part, Organ, or Organ Component]
   755 E C0221908:Epithelial [Qualitative Concept]
   755 E C0333610:Pigmented [Qualitative Concept]

Phrase: "and"

Phrase: "the vitreous humour"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0042905:Vitreous Humor [Body Part, Organ, or Organ Component]
  1000   C0229096:Vitreous humor [Body Substance]
   861   C0020168:Humor [Intellectual Product]
   861   C0597811:humor [Therapeutic or Preventive Procedure]
   761 E C0683242:humorousness [Individual Behavior]

Phrase: "were"

Phrase: "peeled"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441602:peeled [Functional Concept]
  1000   C1882308:PEELED [Event]
   966 E C0520893:peel [Pathologic Function]

Phrase: "away"

Phrase: "and"

Phrase: "the lens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023317:Lens [Body Part, Organ, or Organ Component]
  1000   C0023318:Lens [Medical Device]
  1000   C0996842:Lens [Plant]
  1000   C1278892:Lens [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.195: Ten to fourteen retinas were pooled in 0.5 ml PBS and trypsinized by adding DNase I and trypsin-EDTA to final concentrations of 0.02 g/ml and 0.08 mM, respectively, followed by an incubation for 3 min at 37C. 

Phrase: "Ten to fourteen retinas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0035298:Retinas [Body Part, Organ, or Organ Component]
   779 E C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "pooled in 0.5 ml PBS"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0444499:0/5 [Quantitative Concept]
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C0439526:/mL [Quantitative Concept]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   744   C1709595:Pooled [Conceptual Entity]
   744   C2349200:Pooled [Functional Concept]
   711 E C0337051:Pool [Geographic Area]
   711 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "trypsinized by adding DNase I"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   806   C1148702:DNase I [Genetic Function]
   760   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726   C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "trypsin-EDTA to final concentrations of 0.02 g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.08 mM,"

Phrase: "respectively,"

Phrase: "followed by an incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "for 3 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.196: Enzyme activity was inhibited with FCS at a final concentration of 10%, and the tissue was further mechanically dissected by triturating 10 times. 

Phrase: "Enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "inhibited with FCS"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "at a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10%,"

Phrase: "and"

Phrase: "the tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "further mechanically"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1517331:Further [Spatial Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "dissected by triturating 10 times."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0040223:times [Temporal Concept]
   760   C0205239:dissected [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.197: The sample was then spun down gently and the pellet was resuspended in a filtered medium consisting of Dulbeccos modified Eagles medium (DMEM, Gibco-BRL) with antibiotics, 0.5 mM glutamine, 2.5M glutamic acid, 10 mM HEPES (pH 7.4), 12% FCS and 1x B27 (Gibco-BRL). 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "spun down gently"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1446863:Spun [Laboratory Procedure]
   790   C1638411:Gently [Qualitative Concept]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "and"

Phrase: "the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in a filtered medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726   C0180860:Filter [Manufactured Object]
   726   C0581406:Filter [Medical Device]
   726   C1522664:Filter [Intellectual Product]
   726   C1704449:Filter [Conceptual Entity]
   726   C1704684:Filter [Medical Device]
   726   C1875155:FILTER [Medical Device]

Phrase: "consisting of Dulbeccos"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "Eagles medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(DMEM,"

Phrase: "Gibco-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "with antibiotics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "0.5 mM glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "2.5M glutamic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0523665:Glutamic Acid [Laboratory Procedure]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "10 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "12% FCS"

Phrase: "and"

Phrase: "1x B27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1537935:B27 [Gene or Genome]

Phrase: "(Gibco-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.198: Cells were plated on Matrigel-coated (1:50 in DMEM; 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on Matrigel-coated"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0065749:matrigel [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   770   C1522408:Coated [Qualitative Concept]
   737   C0005971:Plate [Medical Device]
   737 E C0453946:Coat [Manufactured Object]
   737   C1139930:plate [Medical Device]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]
   737   C3537155:Plate [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50 in DMEM"

Phrase: ";"
Processing 00000000.tx.199: Becton Dickinson) 5 cm2 dish with coverslips. 

Phrase: "Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")"

Phrase: "5 cm2 dish with coverslips."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.200: After 4 days of incubation, culturing was continued in the medium without glutamic acid and with or without an antimitotic agent, cytosine arabinoside (AraC 5 M, Sigma). 

Phrase: "After 4 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442765:4 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of incubation,"

Phrase: "culturing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "continued in the medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C0549178:Continued [Idea or Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "without glutamic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523665:Glutamic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "or without an antimitotic agent,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0003379:Antimitotic agent [Pharmacologic Substance]
           antimitotic
   760   C0450442:Agent [Chemical Viewed Functionally]
   760   C1254351:Agent [Pharmacologic Substance]
   760   C1521826:Agent [Intellectual Product]

Phrase: "cytosine arabinoside"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0010711:Cytosine Arabinoside [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   916 E C0591320:Cytosar [Hazardous or Poisonous Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0010843:Cytosine [Biologically Active Substance,Organic Chemical]

Phrase: "(AraC 5 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: Recombinant SFV and infections The recombinant SFV (SFV-CLN3) was constructed and prepared as described previously (13). 

Phrase: "Recombinant SFV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0036636:Semliki forest virus [Virus]
   902   C0597363:recombinant virus [Virus]
   812   C0042776:Virus [Virus]
   812   C0086312:Forest [Geographic Area]
   812   C0319157:virus [Virus]

Phrase: "and"

Phrase: "infections"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infections [Disease or Syndrome]
   916 E C0439663:Infected [Functional Concept]
   884 E C0030657:infectivity [Qualitative Concept]

Phrase: "The recombinant SFV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0036636:Semliki forest virus [Virus]
   902   C0597363:recombinant virus [Virus]
   812   C0042776:Virus [Virus]
   812   C0086312:Forest [Geographic Area]
   812   C0319157:virus [Virus]

Phrase: "(SFV-CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0751383:CLN3 [Disease or Syndrome]
   812   C1413495:CLN3 [Gene or Genome]
   756   C0036636:Semliki forest virus [Virus]

Phrase: ")"

Phrase: "was"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.202: The infections of the retinal cells were performed with the viral solution diluted in medium consisting of Eagles minimal essential medium (MEM) with 0.2% bovine serum albumin (BSA), 2 mM glutamine and 20 mM HEPES. 

Phrase: "The infections of the retinal cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0009450:Infections [Disease or Syndrome]

Phrase: "were"

Phrase: "performed with the viral solution"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0037633:Solution [Substance]
   760   C0521026:Viral [Functional Concept]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "in medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009458:Medium [Intellectual Product]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "consisting of Eagles minimal essential medium (MEM)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0009458:Medium [Intellectual Product]
   753   C0205224:Essential [Qualitative Concept]
   753   C0325564:Eagles [Bird]
   753   C0439536:Medium [Quantitative Concept]
   753   C0547040:Minimal [Qualitative Concept]
   753   C1524031:MINIMAL [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C2945599:Minimal [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]
   719   C0332529:CONSIST [Qualitative Concept]
   719 E C1551720:Eagle [Population Group]

Phrase: "with 0.2% bovine serum albumin (BSA),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "2 mM glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "20 mM HEPES."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.203: Retinal cells to be infected had been maintained in culture for 67 days. 

Phrase: "Retinal cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C2338017:Retinal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "be"

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "had"

Phrase: "been"

Phrase: "maintained in culture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1314677:Maintained [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C0024501:Maintain [Activity]

Phrase: "for 67 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.204: The infection was carried out for 1 h at 37C in 5% CO2, then the infection medium was removed and the incubation was continued for 10 h. 

Phrase: "The infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out for 1 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0439787:Out [Spatial Concept]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0849355:Out [Qualitative Concept]

Phrase: "at 37C"

Phrase: "in 5% CO2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the infection medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the incubation"

Phrase: "was"

Phrase: "continued for 10 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0549178:Continued [Idea or Concept]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.205: Immunofluorescence staining and confocal microscopy Retinal cells were fixed with fresh 4% paraformaldehyde in PBS for 15 min at room temperature, washed with PBS and permeabilized with 0.1% Triton X-100 (Sigma) in 0.5% BSA (Sigma)/PBS for 15 min. 

Phrase: "Immunofluorescence staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "confocal microscopy Retinal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C2338017:Retinal cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed with fresh 4% paraformaldehyde"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]
   760   C2827486:Fresh [Body Substance]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "washed with PBS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "permeabilized with 0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0242759:Triton [Geographic Area]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in 0.5% BSA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "/PBS for 15 min."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.206: Unspecific binding was blocked with 0.5% BSA in PBS for 30 min. 

Phrase: "Unspecific binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked with 0.5% BSA"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   814   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   778   C0444499:0/5 [Quantitative Concept]
   778   C0728877:serum albumin [Laboratory or Test Result]
   774 E C0523465:Albumin - serum [Laboratory Procedure]
   748   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007452:Bovine [Mammal]
   748   C0028778:Blocked [Pathologic Function]
   748   C0229671:Serum [Body Substance]
   748   C0332206:Blocked [Functional Concept]
   748   C1140701:bovine [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.207: For double immunostainings of the non-infected retinal cells, the polyclonal antibody m385 was combined either with mouse anti-tubulin  III isoform (Chemicon, dilution 1:200), rat anti-mouse Lamp1 (developed by J.T.August, Johns Hopkins University School of Medicine, Baltimore, MD; 

Phrase: "For double immunostainings"

Phrase: "of the non-infected retinal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C2338017:Retinal cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the polyclonal antibody m385"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "either with mouse anti-tubulin  III isoform"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439070:III [Intellectual Product]
   748   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   748   C1705160:III [Qualitative Concept]
   748   C2937342:tubulin [Cell Component]

Phrase: "(Chemicon,"

Phrase: "dilution 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: ","

Phrase: "rat anti-mouse Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1416788:LAMP1 [Gene or Genome]
   812   C3540818:LAMP-1 [Gene or Genome]

Phrase: "("

Phrase: "developed by J.T.August,"

Phrase: "Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036375:School [Manufactured Object,Organization]
   753   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD"

Phrase: ";"
Processing 00000000.tx.208: 1:50), mouse anti-SVs (SV2) (developed by K.M.

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50"

Phrase: ")"

Phrase: ","

Phrase: "mouse anti-SVs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0039065:Synaptic Vesicles [Cell Component]
   812   C0333262:VESICLES [Acquired Abnormality]
   779 E C1622418:vesicle [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]

Phrase: "(SV2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427005:SV2 [Gene or Genome]

Phrase: ")"

Phrase: "("

Phrase: "developed by K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.209: Buckley, Harvard Medical School, Boston, MA; 

Phrase: "Buckley,"

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ";"
Processing 00000000.tx.210: 1:50) or mouse anti-growth associated protein 43 (GAP-43) (Boehringer Mannheim; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50"

Phrase: ")"

Phrase: "or"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "anti-growth associated protein 43 (GAP-43)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0068563:Growth Associated Protein 43 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1414967:GROWTH-ASSOCIATED PROTEIN 43 [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]

Phrase: "(Boehringer Mannheim"

Phrase: ";"
Processing 00000000.tx.211: 1:1000). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")."
Processing 00000000.tx.212: Lamp1 and SV2 were obtained from the Developmental Studies Hybridoma Bank, University of Iowa, Department of Biological Sciences, Iowa City, IA, USA under contract NO1-HD-7-3263. 

Phrase: "Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416788:LAMP1 [Gene or Genome]
  1000   C3540818:LAMP-1 [Gene or Genome]

Phrase: "and"

Phrase: "SV2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427005:SV2 [Gene or Genome]

Phrase: "were"

Phrase: "obtained from the Developmental Studies Hybridoma Bank,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0020204:Hybridoma [Cell]
   748   C0442598:Bank [Manufactured Object]
   748   C0458003:Developmental [Qualitative Concept]
   748   C0678723:Developmental [Organism Function]
   748   C0872261:Bank [Manufactured Object]
   748   C0947630:studies [Laboratory Procedure]
   748   C1301820:Obtained [Functional Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C1706701:Obtain [Activity]
   714 E C2603343:Study [Research Activity]

Phrase: "University of Iowa,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022037:Iowa [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1555231:Iowa [Population Group]

Phrase: "Department of Biological Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Iowa City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0022037:Iowa [Geographic Area]
   861   C1555231:Iowa [Population Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "IA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947960:Ia [Mammal]

Phrase: "USA under contract NO1-HD-7-3263."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0041703:USA [Geographic Area]
Processing 00000000.tx.213: SFV-CLN3 infected retinal cells were double immunostained with h385 (1:500) combined with either mouse anti-tubulin  III isoform, rat anti-mouse Lamp1, or mouse anti-SV2. 

Phrase: "SFV-CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0751383:CLN3 [Disease or Syndrome]
   812   C1413495:CLN3 [Gene or Genome]
   756   C0036636:Semliki forest virus [Virus]

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "retinal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2338017:Retinal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "immunostained with h385"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "combined with either mouse anti-tubulin  III isoform,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205195:Combined [Qualitative Concept]
   744   C0439070:III [Intellectual Product]
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   744   C1705160:III [Qualitative Concept]
   744   C2937342:tubulin [Cell Component]
   711 E C0336789:Combine [Manufactured Object]

Phrase: "rat anti-mouse Lamp1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1416788:LAMP1 [Gene or Genome]
   812   C3540818:LAMP-1 [Gene or Genome]

Phrase: "or"

Phrase: "mouse anti-SV2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1427005:SV2 [Gene or Genome]
Processing 00000000.tx.214: Primary antibodies were diluted in blocking buffer and incubated for 1 h at room temperature. 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "diluted in blocking buffer"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.215: Secondary antibody incubation was performed with Rhodamine Red (TRITC)-conjugated goat anti-rabbit IgG (Immunotech; 

Phrase: "Secondary antibody incubation"

Phrase: "was"

Phrase: "performed with Rhodamine Red (TRITC"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0076308:TRITC [Organic Chemical,Pharmacologic Substance]
   760   C0332575:Red [Finding]
   760   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0884358:Performed [Functional Concept]
   760   C1260956:Red [Qualitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: ")-"

Phrase: "conjugated goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0034493:Rabbit [Mammal]

Phrase: "(Immunotech"

Phrase: ";"
Processing 00000000.tx.216: 1:200) combined either with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG+IgM (the Jackson Laboratories; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "either with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG+IgM ("
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   757   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0051980:anti-IgM [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0018019:goat [Mammal]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0124209:Isothiocyanate [Organic Chemical]
   739   C0206359:isothiocyanate [Organic Chemical]
   739   C0522529:Conjugated [Spatial Concept]
   739   C1265549:goat [Mammal]
   739   C1510458:Goat [Mammal]

Phrase: "the Jackson Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ";"
Processing 00000000.tx.217: 1:200) or FITC-conjugated goat anti-rat IgG (Immunotech; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "or"

Phrase: "FITC-conjugated goat anti-rat IgG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]

Phrase: "(Immunotech"

Phrase: ";"
Processing 00000000.tx.218: 1:150). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "150"

Phrase: ")."
Processing 00000000.tx.219: The coverslips were mounted in GelMount (Biomeda Corp.) and viewed with a Leica DMR confocal microscope with TCS NT software (Leica Microscope and Scientific Instruments Group). 

Phrase: "The coverslips"

Phrase: "were"

Phrase: "mounted in GelMount"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]

Phrase: "(Biomeda Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "and"

Phrase: "viewed with a Leica DMR confocal microscope"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1626420:Confocal microscope [Medical Device]
   748   C0181839:Microscope [Medical Device]
   748   C1426317:DMR [Gene or Genome]
   748   C1706379:Microscope [Medical Device]
   714   C0449911:View [Spatial Concept]

Phrase: "with TCS NT software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Leica Microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "and"

Phrase: "Scientific Instruments Group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.220: The confocal images were completed with Adobe Illustrator 8.0 software. 

Phrase: "The confocal images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "completed with Adobe Illustrator 8.0 software."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037585:Software [Intellectual Product,Manufactured Object]
   748   C0205197:COMPLETED [Qualitative Concept]
Processing 00000000.tx.221: Tissue fractionation To provide the PNS 10 cortices from 2-month-old mice were gently homogenized in 60 ml SolA buffer (320 mM sucrose, 5mM Na-HEPES/HCl pH 7.4) with 12 strokes at 800 r.p.m. in a glass-Teflon homogenizer. 

Phrase: "Tissue fractionation To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016640:fractionation [Laboratory Procedure]
   827   C0524811:fractionation [Therapeutic or Preventive Procedure]
   827   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the PNS 10 cortices from 2-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0007776:Cortex [Body Part, Organ, or Organ Component]
   706   C1176472:Cortex [Body Part, Organ, or Organ Component]
   706   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "homogenized in 60 ml SolA buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(320 mM sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "5mM Na-HEPES/HCl pH 7.4"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   829   C2678549:PH-4 [Gene or Genome]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C1272460:{NA} [Qualitative Concept]

Phrase: ")"

Phrase: "with 12 strokes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038454:Strokes [Disease or Syndrome]

Phrase: "at 800 r.p.m."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "in a glass-Teflon homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.222: The homogenate was centrifuged (1000 g, SS34) for 5 min. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(1000 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "SS34"

Phrase: ")"

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.223: For the pelleting analyses, the PNS was centrifuged at 14 500 g for 20 min in a Beckman Tabletop Ultracentrifuge. 

Phrase: "For the pelleting analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "the PNS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "centrifuged at 14 500 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in a Beckman Tabletop Ultracentrifuge."
Processing 00000000.tx.224: The supernatant (S1) was retained and the pellet (P1) was washed with Sol A and recentrifuged at 100000 g for 1 h twice to provide the pellet P2 and supernatant S2. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(S1)"

Phrase: "was"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "and"

Phrase: "the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "(P1)"

Phrase: "was"

Phrase: "washed with Sol A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "recentrifuged at 100000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "for 1 h twice to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0700308:1 H [Element, Ion, or Isotope]
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
   812   C1720725:Twice [Intellectual Product]
   812   C1948050:Twice [Quantitative Concept]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the pellet P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1384585:P2 [Immunologic Factor]
   861   C1419693:P2 [Gene or Genome]
   861   C1539372:p2 [Gene or Genome]

Phrase: "and"

Phrase: "supernatant S2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1179705:S2 [Body Location or Region]
   861   C1419032:S2 [Gene or Genome]
   861   C1419718:S2 [Gene or Genome]
Processing 00000000.tx.225: The pellets were resuspended in 0.2% SDS in HEPES pH 7.4. 

Phrase: "The pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 0.2% SDS"

Phrase: "in HEPES pH 7.4."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C2678549:PH-4 [Gene or Genome]
   861   C1882074:pH 7 [Qualitative Concept]
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
Processing 00000000.tx.226: Isolation of synaptosomes of mouse brain was performed as described by Gordon-Weeks (31,32) and Lehtovirta (15). 

Phrase: "Isolation of synaptosomes of mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Gordon-Weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439230:weeks [Temporal Concept]
   770   C1552738:described [Idea or Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: "and"

Phrase: "Lehtovirta"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.227: The PNS was centrifuged twice at 12 000 g SS34 for 20min and the crude synaptosomal fraction was resuspended in SolA buffer. 

Phrase: "The PNS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "twice at 12 000 g SS34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439267:g% [Quantitative Concept]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]

Phrase: "for 20min"

Phrase: "and"

Phrase: "the crude synaptosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "resuspended in SolA buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.228: This sample was layered on a discontinuous sucrose gradient of 1.2 M/1.0 M/0.85 M. 

Phrase: "This sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "layered on a discontinuous sucrose gradient of 1.2"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   762   C0806243:Gradient 2 [Quantitative Concept]
   742   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0439599:Discontinuous [Temporal Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C0934502:Layered [Body Part, Organ, or Organ Component]
   742   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   742   C1444662:Discontinuous [Finding]
   708 E C1522408:Layer [Qualitative Concept]
   708 E C1561599:Layer [Intellectual Product]

Phrase: "M/"

Phrase: "1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "M/"

Phrase: "0.85 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.229: After centrifugation for 2 h at 110 000 g. in a SW28 rotor (Beckman) the synaptosomes were collected at the 1.0M/1.2M interphase, and resuspended in Krebs solution [NaCl, KCl, CaCl2(H2O)2, MgCl2, NaH2PO4, D-glucose, N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid)]. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 110 000 g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "in a SW28 rotor"

Phrase: "(Beckman"

Phrase: ")"

Phrase: "the synaptosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039067:Synaptosomes [Cell Component]

Phrase: "were"

Phrase: "collected at the 1.0M/1.2M interphase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021798:Interphase [Cell Function]
   744   C1516695:Collected [Idea or Concept]
   744   C1516698:Collected [Functional Concept]
   744   C3171718:2M [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in Krebs solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0064411:Krebs solution [Organic Chemical,Pharmacologic Substance]
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "[NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C1959973:% NaCl [Quantitative Concept]

Phrase: "KCl,"

Phrase: "CaCl2"

Phrase: "(H2O"

Phrase: ")"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "NaH2PO4,"

Phrase: "D-"

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "N-(2-hydroxyethyl"

Phrase: ")"

Phrase: "piperazine-N'-(2-ethanesulfonic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0206794:ethanesulfonic acid [Organic Chemical,Pharmacologic Substance]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.230: SVs were isolated as described previously (33,34). 

Phrase: "SVs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039065:Synaptic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.231: Ten cortices from 2-month-old mice were homogenized in 50 ml buffered sucrose (320 mM sucrose/4 mM Na-HEPES/HCl pH7.3). 

Phrase: "Ten cortices from 2-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0007776:Cortex [Body Part, Organ, or Organ Component]
   714   C1176472:Cortex [Body Part, Organ, or Organ Component]
   714   C2700441:Cortex [Plant]

Phrase: "were"

Phrase: "homogenized in 50 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "buffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "(320 mM sucrose/4 mM Na-HEPES/HCl pH7.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   790   C1272460:{NA} [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.232: The crude SV fraction obtained by differential centrifugation was resuspended in 40 mM sucrose and layered on a linear continuous sucrose gradient 800/50 mM. 

Phrase: "The crude SV fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "obtained by differential centrifugation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0443199:Differential [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1705242:Differential [Qualitative Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "was"

Phrase: "resuspended in 40 mM sucrose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0439509:/40 [Temporal Concept]
   760   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "layered on a linear continuous sucrose gradient 800/50 mM."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   739   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0205132:Linear [Spatial Concept]
   739   C0439182:% gradient [Quantitative Concept]
   739   C0549178:Continuous [Idea or Concept]
   739   C0812409:Gradient [Quantitative Concept]
   739   C0934502:Layered [Body Part, Organ, or Organ Component]
   739   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   706 E C1522408:Layer [Qualitative Concept]
   706 E C1561599:Layer [Intellectual Product]
Processing 00000000.tx.233: Gradients were centrifuged for 5 h at 90 000 g in a SW28 rotor (Beckman). 

Phrase: "Gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "centrifuged for 5 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 90 000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "in a SW28 rotor"

Phrase: "(Beckman"

Phrase: ")."
Processing 00000000.tx.234: Gradients were collected in 1 ml fractions and the refractive index of each fraction was examined. 

Phrase: "Gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "collected in 1 ml fractions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0439526:/mL [Quantitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "the refractive index of each fraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034952:Refractive Index [Quantitative Concept]
   753   C0918012:Index [Intellectual Product]
   753   C1552854:index [Idea or Concept]
   753   C1637833:% index [Quantitative Concept]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.235: Corresponding fractions of two identical gradients were pooled to a final volume of 2 ml and 1.5 ml of each fraction containing vesicles was resuspended in 10 mM Na-HEPES/HCl pH 7.4, 150 mM NaCl, and sedimented by centrifugation for 13 h at 205 000 g in a 70Ti rotor (Beckman). 

Phrase: "Corresponding fractions of two identical gradients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1264633:Fraction of [Quantitative Concept]
           Fractions
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "pooled to a final volume of 2 ml"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   767   C0808397:Volume 2 [Quantitative Concept]
   744   C0205088:Final [Temporal Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C0449468:*Volume [Quantitative Concept]
   744   C1546485:Final [Idea or Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C1709595:Pooled [Conceptual Entity]
   744   C2349200:Pooled [Functional Concept]
   744   C2700258:Volume [Laboratory Procedure]
   711 E C0337051:Pool [Geographic Area]
   711 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "1.5 ml of each fraction containing vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in 10 mM Na-HEPES/HCl pH 7.4,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C1882074:pH 7 [Qualitative Concept]
   757   C2678549:PH-4 [Gene or Genome]
   739   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0020283:[pH] [Quantitative Concept]
   739   C0450407:ph+ [Finding]
   739   C0450408:ph++ [Finding]
   739   C0450409:ph+++ [Finding]
   739   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1272460:{NA} [Qualitative Concept]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "sedimented by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1550099:Sediment [Body Substance]

Phrase: "for 13 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 205 000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "in a 70Ti rotor"

Phrase: "(Beckman"

Phrase: ")."
Processing 00000000.tx.236: The pellets were dissolved in Krebs solution. 

Phrase: "The pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "dissolved in Krebs solution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0064411:Krebs solution [Organic Chemical,Pharmacologic Substance]
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]
   737   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.237: Lysosomes were isolated by homogenizing two 2-month-old mice cortices in 2 ml 250 mM sucrose, 3 mM imidazole-HCL pH 7.4 (buffer A), and passaging them through a 21-gauge needle (35). 

Phrase: "Lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "were"

Phrase: "isolated by homogenizing two 2-month-old mice cortices"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0205409:Isolated [Functional Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   708   C0007776:Cortex [Body Part, Organ, or Organ Component]
   708 E C0370215:Isolate [Substance]
   708   C1176472:Cortex [Body Part, Organ, or Organ Component]
   708 E C1875400:ISOLATE [Pharmacologic Substance]
   708   C2700441:Cortex [Plant]

Phrase: "in 2 ml 250 mM sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "3 mM imidazole-HCL pH 7.4"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   893   C0442757:3 4 [Finding]
   829   C2678549:PH-4 [Gene or Genome]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   795   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]
   795   C0439086:<3 [Quantitative Concept]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C2827736:3+ [Quantitative Concept]
   795   C2981702:3+ [Classification]

Phrase: "(buffer A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "passaging"

Phrase: "them through a 21-gauge needle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C3640175:Needle Gauge [Quantitative Concept]
   753   C0027551:Needle [Medical Device]
   753   C0456564:Gauge [Spatial Concept]
   753   C1521879:GAGE [Immunologic Factor]
   753   C1704318:Needle [Medical Device]
   753   C1882041:Needle [Spatial Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.238: The homogenate was centrifuged and the PNS was layered on top of a step gradient of the following composition: 2 M sucrose, Percoll (Amersham) in buffer A with the density adjusted to 1.090 g/ml, and with a density of 1.075 g/ml. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "the PNS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "layered on top of a step gradient of the following composition"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   738   C0439182:% gradient [Quantitative Concept]
   738   C0486616:Composition [Clinical Attribute]
   738   C0812409:Gradient [Quantitative Concept]
   738   C0934502:Layered [Body Part, Organ, or Organ Component]
   738   C1261552:Step [Conceptual Entity]
   738   C1555710:composition [Idea or Concept]
   738   C1704379:Step [Functional Concept]
   738   C1704458:Top [Spatial Concept]
   738   C1705117:Step [Quantitative Concept]
   738   C2825408:Step [Manufactured Object]
   704   C0332283:follow [Temporal Concept]
   704 E C1522408:Layer [Qualitative Concept]
   704 E C1561599:Layer [Intellectual Product]
   704   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "2 M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "Percoll"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Amersham"

Phrase: ")"

Phrase: "in buffer A"

Phrase: "with the density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "adjusted to 1.090 g/ml,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1300565:g/mL [Quantitative Concept]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0456081:Adjusted [Functional Concept]

Phrase: "and with a density of 1.075 g/ml."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C1300565:g/mL [Quantitative Concept]
   762   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0178587:density [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1515981:And [Idea or Concept]
Processing 00000000.tx.239: Centrifugation was performed in a Beckman 65.1Vti rotor for 40 min at 45 000 g and stopped without braking. 

Phrase: "Centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed in a Beckman 65.1Vti rotor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0450385:65 [Intellectual Product]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 40 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 45 000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "stopped without braking."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0337108:braking [Manufactured Object]
   790   C1272691:stopped [Qualitative Concept]
   756 E C1706206:Brake [Manufactured Object]
   756 E C1947925:Stop [Activity]
   756 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.240: Fractions of 0.5 ml were collected. 

Phrase: "Fractions of 0.5 ml"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1264633:Fraction of [Quantitative Concept]
           Fractions
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.241: The purity of all organelle fractions was assessed by immunoblotting with organelle specific markers. 

Phrase: "The purity of all organelle fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882508:Purity [Quantitative Concept]

Phrase: "was"

Phrase: "assessed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "with organelle specific markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.242: Western blot analysis The protein concentration was measured by Bio-Rad Protein Assay System (Bio-Rad Laboratories) and 5 g of each organelle fraction was electrophoresed in 14% SDSPAGE (36). 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "The protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "measured by Bio-Rad Protein Assay System"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0249069:RAD Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0449913:System [Functional Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(Bio-Rad Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "5 g of each organelle fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "electrophoresed in 14% SDSPAGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0013855:electrophorese [Laboratory Procedure]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.243: The proteins were transferred to nitrocellulose membrane (HybondECL, Amersham Pharmacia Biotech) by electroblotting at 100 mA overnight. 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(HybondECL,"

Phrase: "Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "by electroblotting"

Phrase: "at 100 mA overnight."
Processing 00000000.tx.244: Primary antibodies used for immunostaining were m385 antiserum (1:100), anti-mouse monoclonal synaptophysin (SYP, DAKO; 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used for immunostaining"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "m385 antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: ","

Phrase: "anti-mouse monoclonal synaptophysin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0633763:anti-synaptophysin [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   812   C0085255:Synaptophysin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1420554:SYNAPTOPHYSIN [Gene or Genome]

Phrase: "(SYP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420554:SYP [Gene or Genome]

Phrase: "DAKO"

Phrase: ";"
Processing 00000000.tx.245: 1:1000), rat anti-mouse Lamp1 and, as a negative control, m385 preimmune serum (1:100). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: ","

Phrase: "rat anti-mouse Lamp1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1416788:LAMP1 [Gene or Genome]
   812   C3540818:LAMP-1 [Gene or Genome]

Phrase: "and"

Phrase: ","

Phrase: "as"

Phrase: "a negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "m385 preimmune serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")."
Processing 00000000.tx.246: Secondary antibodies were peroxidase-conjugated swine anti-rabbit, anti-mouse or anti-rat immunoglobulins (1:10000; 

Phrase: "Secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "peroxidase-conjugated swine anti-rabbit, anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "anti-rat immunoglobulins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0021027:Immunoglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0202081:Immunoglobulins NOS [Laboratory Procedure]
   793 E C1621846:immunoglobulin [Molecular Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10000"

Phrase: ";"
Processing 00000000.tx.247: DAKO). 

Phrase: "DAKO"

Phrase: ")."
Processing 00000000.tx.248: To visualize the enhanced chemiluminescence 1.26mM luminol (Fluka) and 0.2 mM p-coumaric acid (Sigma) were used.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "the enhanced chemiluminescence 1.26mM luminol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0024100:Luminol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fluka"

Phrase: ")"

Phrase: "and"

Phrase: "0.2 mM p-coumaric acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.249: ACKNOWLEDGEMENTS  We thank Anne Nyberg and Carina von Schantz for their excellent technical assistance. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Anne Nyberg"

Phrase: "and"

Phrase: "Carina von Schantz for their excellent technical assistance."
Processing 00000000.tx.250: Mikko Jalanko, Jaakko Patrakka and Laura Walliander are thanked for their help with the figures and Tanja Meriluoto for the help with preparing the manuscript. 

Phrase: "Mikko Jalanko,"

Phrase: "Jaakko Patrakka"

Phrase: "and"

Phrase: "Laura Walliander"

Phrase: "are"

Phrase: "thanked for their"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2986676:THANK [Gene or Genome]

Phrase: "help with the figures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018896:Help [Social Behavior]
   770   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "Tanja Meriluoto for the"

Phrase: "help with preparing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018896:Help [Social Behavior]
   790   C1552861:help [Idea or Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.251: This study was financially supported by the Academy of Finland (Center of Excellence in Disease Genetics, grants 44870 and 45289), the Hjelt Fund, the Sigrid Juselius Foundation and MD PhD program of the Helsinki University Medical School.  

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "financially"

Phrase: "supported by the Academy of Finland"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0000876:Academy [Organization]
   753   C0016132:Finland [Geographic Area]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "(Center of Excellence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205099:Center [Spatial Concept]

Phrase: "in Disease Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "grants 44870"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018173:Grants [Quantitative Concept]
   827 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "45289"

Phrase: ")"

Phrase: ","

Phrase: "the Hjelt Fund,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016820:Fund [Quantitative Concept]

Phrase: "the Sigrid Juselius Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "MD PhD program of the Helsinki University Medical School."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1709697:Program [Conceptual Entity]
   742   C2728259:Program [Pharmacologic Substance]
   742   C3484370:Program [Functional Concept]
Processing 00000000.tx.252: FOOTNOTES  + To whom correspondence should be addressed. 

Phrase: "FOOTNOTES  +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.253: Tel: +358 9 47448392; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+358 9 47448392"

Phrase: ";"
Processing 00000000.tx.254: Fax: +358 9 47448480; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+358 9 47448480"

Phrase: ";"
Processing 00000000.tx.255: Email: anu.jalanko@ktl.fi  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Santavuori, P., Lauronen, L., Kirveskari, E., berg, L., Sainio, K. and Autti, T. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "anu.jalanko@ktl.fi"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Santavuori,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lauronen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kirveskari,"

Phrase: "E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "berg,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sainio,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Autti,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.256: (2000) Neuronal ceroid lipofuscinoses in childhood. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuronal ceroid lipofuscinoses in childhood."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0027877:Neuronal Ceroid-Lipofuscinoses [Disease or Syndrome]
           ceroid lipofuscinosis
   760   C0007831:Ceroid [Biologically Active Substance,Lipid]
   760   C0521390:Neuronal [Immunologic Factor]
   726   C0268279:Lipofuscinosis [Disease or Syndrome]
Processing 00000000.tx.257: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.258: Sci., 21, S35S41.[ISI][Medline] 2 The International Batten Disease Consortium. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "21,"

Phrase: "S35S41."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "The International Batten Disease Consortium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1513822:Consortium [Professional or Occupational Group]
   812   C1880171:Consortium [Professional or Occupational Group]
Processing 00000000.tx.259: (1995) Isolation of a novel gene underlying Batten disease, CLN3. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Isolation of a novel gene underlying Batten disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]

Phrase: "CLN3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]
Processing 00000000.tx.260: Cell, 82, 949957.[ISI][Medline] 3 Mole, S. and Gardiner, M. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "82,"

Phrase: "949957."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3 Mole,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   789 E C0026367:Molar [Body Part, Organ, or Organ Component]
   755 E C0027962:moles [Neoplastic Process]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039067:Synaptosomes [Cell Component]

Phrase: "and"

Phrase: "Gardiner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.261: (1999) Molecular genetics of the neuronal ceroid lipofuscinoses. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Molecular genetics of the neuronal ceroid lipofuscinoses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   748   C0017398:Genetics [Biomedical Occupation or Discipline]
   748   C0017399:genetics [Biologic Function]
   748   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.262: Epilepsia, 40, 2932.[Medline] 4 Goebel, H.H. 

Phrase: "Epilepsia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014544:epilepsia [Disease or Syndrome]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "2932."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 4 Goebel,"

Phrase: "H.H."
Processing 00000000.tx.263: (1997) Morphologic diagnosis in neuronal ceroid lipofuscinosis. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Morphologic diagnosis in neuronal ceroid lipofuscinosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011900:Diagnosis [Finding]
   753   C1704338:diagnosis [Qualitative Concept]
   753   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.264: Neuropediatrics, 28, 6769.[ISI][Medline] 5 Palmer, D.N., Fearnley, I.M., Walker, J.E., Hall, N.A., Lake, B.D., Wolfe,L.S., Haltia, M., Martinus, R.D. and Jolly, R.D. 

Phrase: "Neuropediatrics,"

Phrase: "28,"

Phrase: "6769."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5 Palmer,"

Phrase: "D."

Phrase: "N., Fearnley,"

Phrase: "I.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "J.E.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0456647:J/day [Quantitative Concept]
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: "Hall,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Lake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337049:Lake [Geographic Area]
  1000   C1036400:Lake [Amphibian]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wolfe,"

Phrase: "L.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039067:Synaptosomes [Cell Component]

Phrase: "Haltia,"

Phrase: "M."

Phrase: ","

Phrase: "Martinus,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Jolly,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.265: (1992) Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0337174:Storage [Spatial Concept]
   739   C1698986:Storage [Functional Concept]
   739   C1753314:storage [Cell Component]

Phrase: "(Batten disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0751383:Batten Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.266: Am. 

Phrase: "Am."
Processing 00000000.tx.267: J. 

Phrase: "J."
Processing 00000000.tx.268: Med. 

Phrase: "Med."
Processing 00000000.tx.269: Genet., 42, 561567.[ISI][Medline] 6 Santavuori, P. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "42,"

Phrase: "561567."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 6 Santavuori,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.270: (1988) Neuronal ceroid-lipofuscinoses in childhood. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Neuronal ceroid-lipofuscinoses in childhood."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0027877:Neuronal Ceroid-Lipofuscinoses [Disease or Syndrome]
           ceroid lipofuscinosis
   760   C0007831:Ceroid [Biologically Active Substance,Lipid]
   760   C0521390:Neuronal [Immunologic Factor]
   726   C0268279:Lipofuscinosis [Disease or Syndrome]
Processing 00000000.tx.271: Brain Dev., 10, 8083.[ISI][Medline] 7 Janes, R.W., Munroe, P.B., Mitchison, H.M., Gardiner, R.M., Mole, S.E. and Wallace, B.A. 

Phrase: "Brain Dev.,"

Phrase: "10,"

Phrase: "8083."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 7 Janes,"

Phrase: "R.W., Munroe,"

Phrase: "P.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539794:P-B [Gene or Genome]

Phrase: "Mitchison,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Gardiner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Mole,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   928 E C0026367:Molar [Body Part, Organ, or Organ Component]
   893 E C0027962:moles [Neoplastic Process]

Phrase: "S.E."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.272: (1996) A model for Batten disease protein CLN3: functional implications from homology and mutations. 

Phrase: "(1996"

Phrase: ")"

Phrase: "A model for Batten disease protein CLN3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0683033:disease model [Intellectual Product]
   774   C0684309:Disease model [Experimental Model of Disease]
   748   C3161035:Model [Intellectual Product]

Phrase: ":"

Phrase: "functional implications from homology"

Phrase: "and"

Phrase: "mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.273: FEBS Lett., 399, 7577.[ISI][Medline] 8 Pearce, D.A., Nosel, S.A. and Sherman, F. 

Phrase: "FEBS Lett.,"

Phrase: "399,"

Phrase: "7577."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8 Pearce,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nosel,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039067:Synaptosomes [Cell Component]

Phrase: "A."

Phrase: "and"

Phrase: "Sherman,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.274: (1999) Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Studies of pH regulation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   881   C1156284:regulation of pH [Organism Function]
           ph regulation
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1327622:Regulation [Biologic Function]
   770   C2603343:Study [Research Activity]

Phrase: "by Btn1p,"

Phrase: "the yeast homolog of human Cln3p."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homolog [Gene or Genome]
Processing 00000000.tx.275: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.276: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.277: Metab., 66, 320323.[ISI][Medline] 9 Jrvel, I., Sainio, M., Rantamki, T., Olkkonen, V.M., Carpen, O., Peltonen, L. and Jalanko, A. 

Phrase: "Metab.,"

Phrase: "66,"

Phrase: "320323."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 9 Jrvel,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sainio,"

Phrase: "M."

Phrase: ","

Phrase: "Rantamki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Olkkonen,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Carpen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950238:Carpen [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Peltonen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Jalanko,"

Phrase: "A."
Processing 00000000.tx.278: (1998) Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "intracellular targeting of the CLN3 protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C1159372:Protein Targeting [Molecular Function]
   753   C1521840:Targeting [Functional Concept]
   719 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "defective in Batten disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]
Processing 00000000.tx.279: Hum. 

Phrase: "Hum."
Processing 00000000.tx.280: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.281: Genet., 7, 8590.[Abstract/Free FullText] 10 Kida, E., Kaczmarski, W., Golabek, A.A., Kaczmarski, A., Michalewski,M. and Wisniewski, K.E. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "8590."

Phrase: "[Abstract/Free FullText"

Phrase: "] 10 Kida,"

Phrase: "E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "Kaczmarski,"

Phrase: "W.,"

Phrase: "Golabek,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Kaczmarski,"

Phrase: "A.,"

Phrase: "Michalewski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "K.E."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]
Processing 00000000.tx.282: (1999) Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Analysis of intracellular distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "trafficking of the CLN3 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0599895:Protein Trafficking [Cell Function]
   797   C1159772:Protein Trafficking [Cell Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0599896:trafficking [Cell Function]
   760   C0751383:CLN3 [Disease or Syndrome]
   760   C1413495:CLN3 [Gene or Genome]

Phrase: "in fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332466:Fusion [Functional Concept]
  1000   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "with the green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.283: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.284: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.285: Metab., 66, 265271.[ISI][Medline] 11 Kremmidiotis, G., Lensink, I.L., Bilton, R.L., Woollatt, E., Chataway,T.K., Sutherland, G.R. and Callen, D.F. 

Phrase: "Metab.,"

Phrase: "66,"

Phrase: "265271."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11 Kremmidiotis,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lensink,"

Phrase: "I.L., Bilton,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Woollatt,"

Phrase: "E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "Chataway,"

Phrase: "T.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sutherland,"

Phrase: "G.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Callen,"

Phrase: "D."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.286: (1999) The Batten disease gene product (CLN3p) is a Golgi integral membrane protein. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The Batten disease gene product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1416989:MAL gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "(CLN3p"

Phrase: ")"

Phrase: "is"

Phrase: "a Golgi integral membrane protein."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C1166861:Golgi integral membrane protein [Cell Component]
   923   C0021699:Integral Membrane Protein [Amino Acid, Peptide, or Protein]
   902   C1423498:golgi protein [Gene or Genome]
   875   C0230764:Golgi membrane [Cell Component]
   861   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0025255:Membrane [Tissue]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443238:Integral [Quantitative Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.287: Hum. 

Phrase: "Hum."
Processing 00000000.tx.288: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.289: Genet., 8, 523531.[Abstract/Free FullText] 12 Margraf, L.R., Boriack, R.L., Routheut, A.A., Cuppen, I., Alhilali, L., Bennett, C.J. and Bennett, M.J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "523531."

Phrase: "[Abstract/Free FullText"

Phrase: "] 12 Margraf,"

Phrase: "L.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Boriack,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Routheut,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Cuppen,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Alhilali,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bennett,"

Phrase: "C.J."

Phrase: "and"

Phrase: "Bennett,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.290: (1999) Tissue expression and subcellular localization of CLN3, the Batten disease protein. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Tissue expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "subcellular localization of CLN3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "the Batten disease protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0751383:Batten Disease [Disease or Syndrome]
Processing 00000000.tx.291: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.292: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.293: Metab., 66, 283289.[ISI][Medline] 13 Jrvel, I., Lehtovirta, M., Tikkanen, R., Kyttl, A. and Jalanko, A. 

Phrase: "Metab.,"

Phrase: "66,"

Phrase: "283289."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 13 Jrvel,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lehtovirta,"

Phrase: "M."

Phrase: ","

Phrase: "Tikkanen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kyttl,"

Phrase: "A."

Phrase: "and"

Phrase: "Jalanko,"

Phrase: "A."
Processing 00000000.tx.294: (1999) Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL). 

Phrase: "(1999"

Phrase: ")"

Phrase: "Defective intracellular transport of CLN3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599814:Intracellular Transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "the molecular basis of Batten disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1853126:MOLECULAR BASIS [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "(JNCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:JNCL [Disease or Syndrome]
  1000   C1413495:JNCL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.295: Hum. 

Phrase: "Hum."
Processing 00000000.tx.296: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.297: Genet., 8, 10911098.[Abstract/Free FullText] 14 Katz, M.L., Gao, C.L., Prabhakaram, M., Shibuya, H., Liu, P.C. and Johnson, G.S. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "10911098."

Phrase: "[Abstract/Free FullText"

Phrase: "] 14 Katz,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gao,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Prabhakaram,"

Phrase: "M."

Phrase: ","

Phrase: "Shibuya,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Liu,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "G.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039067:Synaptosomes [Cell Component]
Processing 00000000.tx.298: (1997) Immunochemical localization of the Batten disease (CLN3) protein in retina. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Immunochemical localization of the Batten disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "(CLN3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]

Phrase: ")"

Phrase: "protein in retina."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.299: Invest. 

Phrase: "Invest."
Processing 00000000.tx.300: Ophthalmol. 

Phrase: "Ophthalmol."
Processing 00000000.tx.301: Vis. 

Phrase: "Vis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571809:VIS [Therapeutic or Preventive Procedure]
Processing 00000000.tx.302: Sci., 38, 23752386.[Abstract] 15 Lehtovirta, M., Kyttl, A., Eskelinen, E.L., Hess, M., Heinonen, O. and Jalanko, A. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "38,"

Phrase: "23752386."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15 Lehtovirta,"

Phrase: "M."

Phrase: ","

Phrase: "Kyttl,"

Phrase: "A.,"

Phrase: "Eskelinen,"

Phrase: "E.L., Hess,"

Phrase: "M."

Phrase: ","

Phrase: "Heinonen,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Jalanko,"

Phrase: "A."
Processing 00000000.tx.303: (2001) Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). 

Phrase: "(2001"

Phrase: ")"

Phrase: "Palmitoyl protein thioesterase (PPT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0380804:palmitoyl-protein thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418854:PALMITOYL-PROTEIN THIOESTERASE [Gene or Genome]
   913   C0030238:Palmitoyl Thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "localizes into synaptosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0039067:Synaptosomes [Cell Component]
   790   C0392752:localize [Spatial Concept]

Phrase: "and"

Phrase: "synaptic vesicles in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0039065:Synaptic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: ":"

Phrase: "implications for infantile neuronal ceroid lipofuscinosis (INCL)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0268281:Infantile neuronal ceroid lipofuscinosis [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.304: Hum. 

Phrase: "Hum."
Processing 00000000.tx.305: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.306: Genet., 10, 6975.[Abstract/Free FullText] 16 Munroe, P.B., Mitchison, H.M., ORawe, A.M., Anderson, J.W., Boustany, R.M., Lerner, T.J., Taschner, P.E., de Vos, N., Breuning, M.H., Gardiner, R.M. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "6975."

Phrase: "[Abstract/Free FullText"

Phrase: "] 16 Munroe,"

Phrase: "P.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539794:P-B [Gene or Genome]

Phrase: "Mitchison,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "ORawe,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Anderson,"

Phrase: "J.W., Boustany,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Lerner,"

Phrase: "T.J.,"

Phrase: "Taschner,"

Phrase: "P.E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: "de Vos,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Breuning,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gardiner,"

Phrase: "R.M. et al."
Processing 00000000.tx.307: (1997) Spectrum of mutations in the Batten disease gene, CLN3. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Spectrum of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1883073:Spectrum [Quantitative Concept]
   790   C2827424:Spectrum [Conceptual Entity]

Phrase: "in the Batten disease gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   873   C1416989:MAL gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0751383:Batten Disease [Disease or Syndrome]

Phrase: "CLN3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751383:CLN3 [Disease or Syndrome]
  1000   C1413495:CLN3 [Gene or Genome]
Processing 00000000.tx.308: Am. 

Phrase: "Am."
Processing 00000000.tx.309: J. 

Phrase: "J."
Processing 00000000.tx.310: Hum. 

Phrase: "Hum."
Processing 00000000.tx.311: Genet., 61, 310316.[ISI][Medline] 17 Salem, N., Faundez, V., Horng, J.T. and Kelly, R.B. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "61,"

Phrase: "310316."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 17 Salem,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Faundez,"

Phrase: "V.,"

Phrase: "Horng,"

Phrase: "J.T."

Phrase: "and"

Phrase: "Kelly,"

Phrase: "R.B."
Processing 00000000.tx.312: (1998) A v-SNARE participates in synaptic vesicle formation mediated by the AP3 adaptor complex. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A v-SNARE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1506158:v-SNARE [Amino Acid, Peptide, or Protein,Receptor]
   827   C0183362:Snare [Medical Device]
   827   C0300824:SNARE [Amino Acid, Peptide, or Protein,Receptor]
   827   C1153540:SNARE [Molecular Function]

Phrase: "participates in synaptic vesicle formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0039065:Synaptic vesicle [Cell Component]
   806   C1749557:vesicle formation [Cell Function]
   760   C0220781:formation [Biologic Function]
   760   C0333262:Vesicle [Acquired Abnormality]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   760   C1622418:vesicle [Cell Component]

Phrase: "mediated by the AP3 adaptor complex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C1706710:Adaptor [Manufactured Object]
Processing 00000000.tx.313: Nat. 

Phrase: "Nat."
Processing 00000000.tx.314: Neurosci., 1, 551556.[ISI][Medline] 18 Haskell, R.E., Carr, C.J., Pearce, D.A., Bennett, M.J. and Davidson, B.L. 

Phrase: "Neurosci.,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "551556."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 18 Haskell,"

Phrase: "R.E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]

Phrase: "Carr,"

Phrase: "C.J.,"

Phrase: "Pearce,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bennett,"

Phrase: "M."

Phrase: "J."

Phrase: "and"

Phrase: "Davidson,"

Phrase: "B.L."
Processing 00000000.tx.315: (2000) Batten disease: evaluation of CLN3 mutations on protein localization and function. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Batten disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0751383:Batten Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "evaluation of CLN3 mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "on protein localization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597704:protein localisation [Cell Function]
  1000   C1159772:Protein Localization [Cell Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.316: Hum. 

Phrase: "Hum."
Processing 00000000.tx.317: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.318: Genet., 9, 735744.[Abstract/Free FullText] 19 Bonifacino, J.S. and DellAngelica, E.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "735744."

Phrase: "[Abstract/Free FullText"

Phrase: "] 19 Bonifacino,"

Phrase: "J.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039067:Synaptosomes [Cell Component]

Phrase: "and"

Phrase: "DellAngelica,"

Phrase: "E.C."
Processing 00000000.tx.319: (1999) Molecular bases for the recognition of tyrosine-based sorting signals. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Molecular bases for the recognition of tyrosine-based sorting signals."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   743   C1853126:MOLECULAR BASIS [Idea or Concept]
   739   C0178499:bases [Chemical Viewed Functionally]
   739   C1626935:Bases [Quantitative Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C1527178:Basis [Functional Concept]
   706 E C1874451:Basis [Pharmacologic Substance]
   706 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.320: J. 

Phrase: "J."
Processing 00000000.tx.321: Cell Biol., 145, 923926.[Free FullText] 20 Hellsten, E., Vesa, J., Olkkonen, V.M., Jalanko, A. and Peltonen, L. 

Phrase: "Cell Biol.,"

Phrase: "145,"

Phrase: "923926."

Phrase: "[Free FullText"

Phrase: "] 20 Hellsten,"

Phrase: "E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "Vesa,"

Phrase: "J.,"

Phrase: "Olkkonen,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jalanko,"

Phrase: "A."

Phrase: "and"

Phrase: "Peltonen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.322: (1996) Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Human palmitoyl protein thioesterase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0380804:palmitoyl-protein thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1418854:PALMITOYL-PROTEIN THIOESTERASE [Gene or Genome]
   875   C0030238:Palmitoyl Thioesterase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "evidence for lysosomal targeting of the enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "disturbed cellular routing in infantile neuronal ceroid lipofuscinosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0013153:ROUTE [Functional Concept]
   711   C0449444:Route [Spatial Concept]
   711   C1879941:ROUTE [Intellectual Product]
Processing 00000000.tx.323: EMBO J., 15, 52405245.[Abstract] 21 Isosomppi, J., Heinonen, O., Hiltunen, J.O., Greene, N.D., Vesa, J., Uusitalo, A., Mitchison, H.M., Saarma, M., Jalanko, A. and Peltonen, L. 

Phrase: "EMBO J.,"

Phrase: "15,"

Phrase: "52405245."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 21 Isosomppi,"

Phrase: "J.,"

Phrase: "Heinonen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Hiltunen,"

Phrase: "J.O.,"

Phrase: "Greene,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Vesa,"

Phrase: "J.,"

Phrase: "Uusitalo,"

Phrase: "A.,"

Phrase: "Mitchison,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Saarma,"

Phrase: "M."

Phrase: ","

Phrase: "Jalanko,"

Phrase: "A."

Phrase: "and"

Phrase: "Peltonen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.324: (1999) Developmental expression of palmitoyl protein thioesterase in normal mice. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Developmental expression of palmitoyl protein thioesterase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in normal mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.325: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.326: Dev. 

Phrase: "Dev."
Processing 00000000.tx.327: Brain Res., 118, 111. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "118,"

Phrase: "111."
Processing 00000000.tx.328: 22 Heinonen, O., Kyttl, A., Lehmus, E., Paunio, T., Peltonen, L. and Jalanko, A. 

Phrase: "22 Heinonen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kyttl,"

Phrase: "A.,"

Phrase: "Lehmus,"

Phrase: "E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "Paunio,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Peltonen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Jalanko,"

Phrase: "A."
Processing 00000000.tx.329: (2000) Expression of palmitoyl protein thioesterase in neurons. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Expression of palmitoyl protein thioesterase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.330: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.331: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.332: Metab., 69, 123129.[ISI][Medline] 23 Lin, L., Sohar, I., Lackland, H. and Lobel, P. 

Phrase: "Metab.,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "123129."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 23 Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sohar,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lackland,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lobel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.333: (2001) The human CLN2 protein/tripeptidyl-peptidase I is a serine proteaseT that autoactivates at acidic pH. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The human CLN2 protein/tripeptidyl-peptidase I"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   919   C1430948:tripeptidyl-peptidase I, human [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0661884:tripeptidyl-peptidase I [Amino Acid, Peptide, or Protein,Enzyme]
           Tripeptidyl peptidase
   861   C1540042:TRIPEPTIDYL PEPTIDASE I [Gene or Genome]
   858   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0077246:Tripeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0021966:I- [Inorganic Chemical]
   799   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1947941:Peptidase [Enzyme]

Phrase: "is"

Phrase: "a serine proteaseT"

Phrase: "that"

Phrase: "autoactivates at acidic pH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001128:Acidic [Chemical]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
Processing 00000000.tx.334: J. 

Phrase: "J."
Processing 00000000.tx.335: Biol. 

Phrase: "Biol."
Processing 00000000.tx.336: Chem., 276, 22492255.[Abstract/Free FullText] 24 Lonka, L., Kyttl, A., Ranta, S., Jalanko, A. and Lehesjoki, A.E. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "276,"

Phrase: "22492255."

Phrase: "[Abstract/Free FullText"

Phrase: "] 24 Lonka,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kyttl,"

Phrase: "A.,"

Phrase: "Ranta,"

Phrase: "S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039067:Synaptosomes [Cell Component]

Phrase: "Jalanko,"

Phrase: "A."

Phrase: "and"

Phrase: "Lehesjoki,"

Phrase: "A.E."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]
Processing 00000000.tx.337: (2000) The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The neuronal ceroid lipofuscinosis CLN8 membrane protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0025255:Membrane [Tissue]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0596901:Membrane [Cell Component]
   799   C1706182:Membrane [Manufactured Object]
   727 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "a resident of the endoplasmic reticulum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1320928:Resident [Professional or Occupational Group]
   753   C1549439:Resident [Intellectual Product]
   753   C2347958:Resident [Human]
Processing 00000000.tx.338: Hum. 

Phrase: "Hum."
Processing 00000000.tx.339: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.340: Genet., 9, 16911697.[Abstract/Free FullText] 25 Braak, H. and Goebel, H.H. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "16911697."

Phrase: "[Abstract/Free FullText"

Phrase: "] 25 Braak,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Goebel,"

Phrase: "H.H."
Processing 00000000.tx.341: (1978) Loss of pigment-laden stellate cells: a severe alteration of the isocortex in juvenile neuronal ceroid-lipofuscinosis. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Loss of pigment-laden stellate cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: ":"

Phrase: "a severe alteration of the isocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515926:Alteration [Idea or Concept]

Phrase: "in juvenile neuronal ceroid-lipofuscinosis."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0751383:Juvenile Neuronal Ceroid Lipofuscinosis [Disease or Syndrome]
           Neuronal lipofuscinosis, juvenile
  1000   C1413495:juvenile neuronal ceroid lipofuscinosis [Gene or Genome]
   923   C0027877:Ceroid-Lipofuscinosis, Neuronal [Disease or Syndrome]
           ceroid lipofuscinosis
   812   C0007831:Ceroid [Biologically Active Substance,Lipid]
   812   C0268279:Lipofuscinosis [Disease or Syndrome]
   812   C0521390:Neuronal [Immunologic Factor]
   741 E C0027882:Neuron [Cell]
Processing 00000000.tx.342: Acta Neuropathol., 42, 5357.[ISI][Medline] 26 Braak, H. and Goebel, H.H. 

Phrase: "Acta Neuropathol.,"

Phrase: "42,"

Phrase: "5357."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 26 Braak,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Goebel,"

Phrase: "H.H."
Processing 00000000.tx.343: (1979) Pigmentoarchitectonic pathology of the isocortex in juvenile neuronal ceroid-lipofuscinosis: axonal enlargements in layer IIIab and cell loss in layer V. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Pigmentoarchitectonic pathology of the isocortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "in juvenile neuronal ceroid-lipofuscinosis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0751383:Juvenile Neuronal Ceroid Lipofuscinosis [Disease or Syndrome]
           Neuronal lipofuscinosis, juvenile
  1000   C1413495:juvenile neuronal ceroid lipofuscinosis [Gene or Genome]
   923   C0027877:Ceroid-Lipofuscinosis, Neuronal [Disease or Syndrome]
           ceroid lipofuscinosis
   812   C0007831:Ceroid [Biologically Active Substance,Lipid]
   812   C0268279:Lipofuscinosis [Disease or Syndrome]
   812   C0521390:Neuronal [Immunologic Factor]
   741 E C0027882:Neuron [Cell]

Phrase: ":"

Phrase: "axonal enlargements in layer IIIab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0020564:enlargements [Pathologic Function]
   726 E C1293134:Enlargement [Therapeutic or Preventive Procedure]
   726 E C2711450:Enlargement [Anatomical Abnormality]

Phrase: "and"

Phrase: "cell loss in layer V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.344: Acta Neuropathol., 46, 7983.[ISI][Medline] 27 March, P.A., Wurzelmann, S. and Walkley, S.U. 

Phrase: "Acta Neuropathol.,"

Phrase: "46,"

Phrase: "7983."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 27 March,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Wurzelmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039067:Synaptosomes [Cell Component]

Phrase: "and"

Phrase: "Walkley,"

Phrase: "S.U."
Processing 00000000.tx.345: (1995) Morphological alterations in neocortical and cerebellar GABAergic neurons in a canine model of juvenile Batten disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Morphological alterations in neocortical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1260954:Morphologic alteration [Anatomical Abnormality]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "cerebellar GABAergic neurons in a canine model of juvenile Batten disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0815002:GABAergic Neurons [Cell]
   738   C0027882:Neurons [Cell]
   737   C0682702:Cerebellar neuron [Cell]
Processing 00000000.tx.346: Am. 

Phrase: "Am."
Processing 00000000.tx.347: J. 

Phrase: "J."
Processing 00000000.tx.348: Med. 

Phrase: "Med."
Processing 00000000.tx.349: Genet., 57, 204212.[ISI][Medline] 28 Masliah, E. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "57,"

Phrase: "204212."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 28 Masliah,"

Phrase: "E."
Processing 00000000.tx.350: (2000) The role of synaptic proteins in Alzheimers disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The role of synaptic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.351: Ann. 

Phrase: "Ann."
Processing 00000000.tx.352: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.353: Y. 

Phrase: "Y."
Processing 00000000.tx.354: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.355: Sci., 924, 6875.[Abstract/Free FullText] 29 Mitchison, H.M., Bernard, D.J., Greene, N.D., Cooper, J.D., Junaid, M.A., Pullarkat, R.K., de Vos, N., Breuning, M.H., Owens, J.W., Mobley, W.C. et al. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "924,"

Phrase: "6875."

Phrase: "[Abstract/Free FullText"

Phrase: "] 29 Mitchison,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Bernard,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Greene,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Junaid,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pullarkat,"

Phrase: "R.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "de Vos,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Breuning,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Owens,"

Phrase: "J.W., Mobley,"

Phrase: "W.C. et al."
Processing 00000000.tx.356: (1999) Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Targeted disruption of the Cln3 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a mouse model for Batten disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2986594:Mouse Model [Experimental Model of Disease]
   783   C0683033:disease model [Intellectual Product]
   783   C0684309:Disease model [Experimental Model of Disease]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.357: The Batten Mouse Model Consortium. 

Phrase: "The Batten Mouse Model Consortium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1513822:Consortium [Professional or Occupational Group]
   812   C1880171:Consortium [Professional or Occupational Group]
Processing 00000000.tx.358: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.359: Dis., 6, 321334.[ISI][Medline] 30 Jaquet, V., Gow, A., Tosic, M., Suchanek, G., Breitschopf, H., Lassmann,H., Lazzarini, R.A. and Matthieu, J.M. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "6,"

Phrase: "321334."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 30 Jaquet,"

Phrase: "V.,"

Phrase: "Gow,"

Phrase: "A.,"

Phrase: "Tosic,"

Phrase: "M."

Phrase: ","

Phrase: "Suchanek,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Breitschopf,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lassmann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."

Phrase: "and"

Phrase: "Matthieu,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.360: (1996) An antisense transgenic strategy to inhibit the myelin oligodendrocyte glycoprotein synthesis. 

Phrase: "(1996"

Phrase: ")"

Phrase: "An antisense transgenic strategy to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0679199:strategy [Mental Process]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the myelin oligodendrocyte glycoprotein synthesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C3146300:glycoprotein synthesis [Molecular Function]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]
   756   C1417228:MYELIN-OLIGODENDROCYTE GLYCOPROTEIN [Gene or Genome]
   756   C3266851:Myelin-Oligodendrocyte Glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0129439:myelin glycoprotein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.361: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.362: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.363: Brain Res., 43, 333337.[ISI][Medline] 31 Gordon-Weeks, P.R. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "43,"

Phrase: "333337."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 31 Gordon-Weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]

Phrase: "P.R."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.364: (1987) The cytoskeletons of isolated, neuronal growth cones. 

Phrase: "(1987"

Phrase: ")"

Phrase: "The cytoskeletons of isolated, neuronal growth cones."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0010853:Cytoskeletons [Cell Component]
   714 E C1748451:Cytoskeleton [Cell Component]
Processing 00000000.tx.365: Neuroscience, 21, 977989.[ISI][Medline] 32 Gordon-Weeks, P.R. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "21,"

Phrase: "977989."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 32 Gordon-Weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]

Phrase: "P.R."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: (1997) Isolation of synaptosomes, growth cones and their subcellular components. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Isolation of synaptosomes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0204727:Isolation [Therapeutic or Preventive Procedure]
   790   C0205409:Isolation [Functional Concept]
   790   C0220862:isolation [Laboratory Procedure]
   718 E C1548221:Isolated [Idea or Concept]

Phrase: "growth cones"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0596632:Growth Cones [Cell Component]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0206428:Cones [Cell]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0330095:Cone [Plant]
   827 E C2350017:Cone [Spatial Concept]

Phrase: "and"

Phrase: "their subcellular components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.367: In Turner, A.J. and Bachelard, H.S. 

Phrase: "In Turner,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "Bachelard,"

Phrase: "H.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039067:Synaptosomes [Cell Component]
Processing 00000000.tx.368: (eds), Neurochemistry. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Neurochemistry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027820:Neurochemistry [Biomedical Occupation or Discipline]
  1000   C0699841:neurochemistry [Organ or Tissue Function]
Processing 00000000.tx.369: A Practical Approach. 

Phrase: "A Practical Approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.370: 2nd edn. 

Phrase: "2nd edn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419408:EDN [Gene or Genome]
Processing 00000000.tx.371: IRL Press, Oxford, UK. 

Phrase: "IRL Press,"

Phrase: "Oxford,"

Phrase: "UK."
Processing 00000000.tx.372: 33 Huttner, W.B., Schiebler, W., Greengard, P. and De Camilli, P. 

Phrase: "33 Huttner,"

Phrase: "W.B.,"

Phrase: "Schiebler,"

Phrase: "W.,"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "De Camilli,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.373: (1983) Synapsin I (protein I), a nerve terminal-specific phosphoprotein. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Synapsin I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0087044:Synapsin I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420543:SYNAPSIN I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0085252:synapsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(protein I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0021966:I- [Inorganic Chemical]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "a nerve terminal-specific phosphoprotein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031689:Phosphoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.374: III. 

Phrase: "III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]
Processing 00000000.tx.375: Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. 

Phrase: "Its association with synaptic vesicles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "studied in a highly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:Highly [Qualitative Concept]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "synaptic vesicle preparation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]
   734   C0039065:Synaptic vesicle [Cell Component]
Processing 00000000.tx.376: J. 

Phrase: "J."
Processing 00000000.tx.377: Cell Biol., 96, 13741388.[Abstract] 34 Beher, D., Elle, C., Underwood, J., Davis, J.B., Ward, R., Karran, E., Masters, C.L., Beyreuther, K. and Multhaup, G. 

Phrase: "Cell Biol.,"

Phrase: "96,"

Phrase: "13741388."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 34 Beher,"

Phrase: "D."

Phrase: ","

Phrase: "Elle,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Underwood,"

Phrase: "J.,"

Phrase: "Davis,"

Phrase: "J.B.,"

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Karran,"

Phrase: "E.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Multhaup,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.378: (1999) Proteolytic fragments of Alzheimers disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proteolytic fragments of Alzheimers disease-associated presenilin 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "present in synaptic organelles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "growth cone membranes of rat brain."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   816   C2245784:growth cone membrane [Cell Component]
   753   C0025255:Membranes [Tissue]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.379: J. 

Phrase: "J."
Processing 00000000.tx.380: Neurochem., 72, 15641573.[ISI][Medline] 35 Diettrich, O., Gallert, F. and Hasilik, A. 

Phrase: "Neurochem.,"

Phrase: "72,"

Phrase: "15641573."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 35 Diettrich,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Gallert,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hasilik,"

Phrase: "A."
Processing 00000000.tx.381: (1996) Purification of lysosomal membrane proteins from human placenta. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Purification of lysosomal membrane proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0597301:protein purification [Laboratory Procedure]
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "from human placenta."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0032043:Placenta [Embryonic Structure]
   861   C1278988:Placenta [Embryonic Structure]
   861   C1550656:Placenta [Body Substance]
   789 E C0230956:Placental [Mammal]
Processing 00000000.tx.382: Eur. 

Phrase: "Eur."
Processing 00000000.tx.383: J. 

Phrase: "J."
Processing 00000000.tx.384: Cell Biol., 69, 99106.[ISI][Medline] 36 Laemmli, U.K. 

Phrase: "Cell Biol.,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "99106."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 36 Laemmli,"

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.385: (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. 

Phrase: "(1970"

Phrase: ")"

Phrase: "Cleavage of structural proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0597304:Protein Cleavage [Molecular Function]
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "during the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "of the head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "of bacteriophage T4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162570:Bacteriophage T4 [Virus]
Processing 00000000.tx.386: Nature, 227, 680685.[ISI][Medline]

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "227,"

Phrase: "680685."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

